falseDecember 310000061986Q1http://fasb.org/us-gaap/2023#OtherAssetsCurrenthttp://fasb.org/us-gaap/2023#OtherAssetsCurrent0000061986us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-310000061986mtw:SeniorNotesDue2026Member2023-12-310000061986us-gaap:FiniteLivedIntangibleAssetsMember2023-12-310000061986us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310000061986us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-03-310000061986srt:DirectorMemberus-gaap:RestrictedStockUnitsRSUMember2024-01-012024-03-310000061986mtw:SeniorNotesDue2026Member2019-03-252019-03-250000061986us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310000061986mtw:SeniorNotesDue2026Member2019-03-2500000619862024-03-310000061986us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310000061986us-gaap:FiniteLivedIntangibleAssetsMember2024-03-310000061986us-gaap:CorporateNonSegmentMember2024-01-012024-03-310000061986us-gaap:AdditionalPaidInCapitalMember2022-12-310000061986us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMembermtw:DeferredCompensationPlanProgramBMemberus-gaap:FairValueMeasurementsRecurringMember2024-03-310000061986us-gaap:PerformanceSharesMember2023-01-012023-03-310000061986us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-01-012024-03-310000061986us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000061986mtw:SeniorSecuredSecondIienNotesDue2026Member2024-03-310000061986us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2023-01-012023-03-310000061986us-gaap:OperatingSegmentsMembermtw:EuropeAndAfricaSegmentMember2023-01-012023-03-310000061986us-gaap:ForeignExchangeContractMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310000061986us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMembermtw:DeferredCompensationPlanProgramBMemberus-gaap:FairValueMeasurementsRecurringMember2024-03-310000061986us-gaap:ForeignExchangeForwardMember2024-03-310000061986us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310000061986mtw:DeferredCompensationPlanProgramBMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-03-310000061986us-gaap:BaseRateMembermtw:ABLRevolvingCreditFacilityMember2024-01-012024-03-310000061986mtw:SeniorSecuredSecondLienNotesMember2024-03-310000061986us-gaap:PerformanceSharesMember2024-01-012024-03-310000061986mtw:NewMachineSalesMember2023-01-012023-03-310000061986us-gaap:IndefinitelivedIntangibleAssetsMemberus-gaap:DistributionRightsMember2024-03-310000061986srt:MaximumMemberus-gaap:CommonStockMember2024-03-310000061986us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2024-03-310000061986us-gaap:FiniteLivedIntangibleAssetsMemberus-gaap:TrademarksAndTradeNamesMember2024-03-310000061986us-gaap:BuildingAndBuildingImprovementsMember2023-12-310000061986mtw:EngineeringSellingAndAdministrativeExpenseMember2024-01-012024-03-310000061986us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-03-310000061986us-gaap:ConstructionInProgressMember2024-03-310000061986us-gaap:FiniteLivedIntangibleAssetsMemberus-gaap:CustomerRelationshipsMember2024-03-310000061986us-gaap:ConstructionInProgressMember2023-12-310000061986us-gaap:OtherCurrentAssetsMember2023-12-310000061986srt:DirectorMemberus-gaap:RestrictedStockUnitsRSUMember2023-01-012023-03-310000061986us-gaap:OperatingSegmentsMembermtw:AmericasSegmentMember2023-01-012023-03-310000061986mtw:AccountsPayableAndAccruedExpensesMember2024-03-310000061986mtw:EuropeAndAfricaSegmentMember2024-03-310000061986us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310000061986us-gaap:RetainedEarningsMember2022-12-310000061986us-gaap:AccumulatedTranslationAdjustmentMember2023-03-310000061986us-gaap:FiniteLivedIntangibleAssetsMemberus-gaap:NoncompeteAgreementsMember2023-12-310000061986us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2024-03-310000061986us-gaap:AdditionalPaidInCapitalMember2023-12-3100000619862023-03-310000061986us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310000061986mtw:A2013OmnibusPlanMember2024-03-310000061986us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-012023-03-310000061986mtw:MiddleEastAndAsiaPacificSegmentMember2023-12-310000061986mtw:GreaterThanOrEqualToFiftyPercentOfAggregateCommitmentMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembermtw:ABLRevolvingCreditFacilityMember2024-01-012024-03-310000061986mtw:AlternativeBaseRateMembermtw:GreaterThanOrEqualToFiftyPercentOfAggregateCommitmentMembermtw:ABLRevolvingCreditFacilityMember2024-01-012024-03-310000061986us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310000061986us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000061986us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310000061986us-gaap:OperatingSegmentsMembermtw:AmericasSegmentMember2024-01-012024-03-310000061986us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2024-03-310000061986us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-03-310000061986us-gaap:LandMember2024-03-3100000619862023-01-012023-12-310000061986us-gaap:OtherCurrentAssetsMember2024-03-310000061986country:US2024-01-012024-03-310000061986us-gaap:CommonStockMember2024-03-310000061986us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310000061986us-gaap:FurnitureAndFixturesMember2023-12-310000061986us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-03-310000061986us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310000061986mtw:SeniorSecuredSecondIienNotesDue2026Member2023-12-310000061986us-gaap:PatentsMemberus-gaap:FiniteLivedIntangibleAssetsMember2024-03-310000061986us-gaap:CommonStockMember2023-03-310000061986us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2023-01-012023-03-310000061986srt:EuropeMember2024-01-012024-03-310000061986country:US2023-01-012023-03-310000061986us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-12-310000061986us-gaap:EstimateOfFairValueFairValueDisclosureMembermtw:DeferredCompensationPlanProgramBMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000061986srt:EuropeMember2023-01-012023-03-310000061986mtw:LesserThanToFiftyPercentOfAggregateCommitmentMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembermtw:ABLRevolvingCreditFacilityMember2024-01-012024-03-310000061986us-gaap:MaterialReconcilingItemsMember2023-01-012023-03-310000061986us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000061986us-gaap:FiniteLivedIntangibleAssetsMemberus-gaap:TrademarksAndTradeNamesMember2023-12-310000061986us-gaap:RetainedEarningsMember2023-12-310000061986us-gaap:AdditionalPaidInCapitalMember2024-03-310000061986us-gaap:ComputerEquipmentMember2024-03-3100000619862024-01-012024-03-310000061986us-gaap:PatentsMemberus-gaap:FiniteLivedIntangibleAssetsMember2023-12-310000061986mtw:OtherCountriesMember2024-01-012024-03-310000061986us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMembermtw:DeferredCompensationPlanProgramBMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000061986us-gaap:BuildingAndBuildingImprovementsMember2024-03-310000061986mtw:OtherDebtMember2023-12-310000061986us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310000061986us-gaap:TreasuryStockCommonMember2023-01-012023-03-310000061986us-gaap:FurnitureAndFixturesMember2024-03-310000061986us-gaap:IndefinitelivedIntangibleAssetsMemberus-gaap:TrademarksAndTradeNamesMember2023-12-310000061986us-gaap:RetainedEarningsMember2023-03-310000061986us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-03-310000061986us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310000061986us-gaap:ForeignExchangeContractMember2024-01-012024-03-310000061986mtw:NonNewMachineSalesMember2024-01-012024-03-310000061986us-gaap:LetterOfCreditMembermtw:ABLRevolvingCreditFacilityMember2019-03-250000061986country:USus-gaap:PensionPlansDefinedBenefitMember2024-01-012024-03-310000061986mtw:NonNewMachineSalesMember2023-01-012023-03-310000061986us-gaap:ForeignExchangeForwardMember2023-12-310000061986us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310000061986mtw:AccountsPayableAndAccruedExpensesMember2023-12-310000061986us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310000061986us-gaap:LandMember2023-12-310000061986mtw:EquipmentsLeasedToOtherPartyMember2024-03-310000061986us-gaap:ForeignExchangeContractMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310000061986mtw:DeferredCompensationPlanProgramBMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000061986us-gaap:TreasuryStockCommonMember2024-03-310000061986mtw:DeferredCompensationPlanProgramBMemberus-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-3100000619862022-12-310000061986us-gaap:TreasuryStockCommonMember2023-03-310000061986us-gaap:CorporateNonSegmentMember2023-01-012023-03-310000061986mtw:PerformanceShares2023Memberus-gaap:PerformanceSharesMember2023-01-012023-03-310000061986us-gaap:RetainedEarningsMember2024-01-012024-03-310000061986mtw:EuropeAndAfricaSegmentMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000061986us-gaap:NondesignatedMemberus-gaap:OtherNonoperatingIncomeExpenseMember2023-01-012023-03-310000061986mtw:NewMachineSalesMember2024-01-012024-03-310000061986mtw:MiddleEastAndAsiaPacificSegmentMember2024-01-012024-03-310000061986us-gaap:MachineryAndEquipmentMember2023-12-310000061986mtw:PerformanceShares2024Memberus-gaap:PerformanceSharesMember2024-01-012024-03-310000061986us-gaap:ForeignExchangeContractMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2024-03-310000061986mtw:EngineeringSellingAndAdministrativeExpenseMember2023-01-012023-03-310000061986us-gaap:IndefinitelivedIntangibleAssetsMember2024-03-310000061986us-gaap:DistributionRightsMemberus-gaap:IndefinitelivedIntangibleAssetsMember2023-12-310000061986us-gaap:TreasuryStockCommonMember2022-12-310000061986mtw:ABLRevolvingCreditFacilityMember2024-03-310000061986us-gaap:RetainedEarningsMember2024-03-310000061986mtw:DeferredCompensationPlanProgramBMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2024-03-310000061986us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000061986us-gaap:LetterOfCreditMembermtw:ABLRevolvingCreditFacilityMember2024-03-310000061986srt:MaximumMember2024-03-310000061986us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2024-03-310000061986us-gaap:IndefinitelivedIntangibleAssetsMember2023-12-310000061986us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-12-310000061986mtw:OtherDebtMember2024-03-310000061986us-gaap:FiniteLivedIntangibleAssetsMembermtw:OtherIntangiblesMember2023-12-310000061986us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-03-310000061986us-gaap:CommonStockMember2023-12-310000061986us-gaap:FiniteLivedIntangibleAssetsMemberus-gaap:NoncompeteAgreementsMember2024-03-310000061986mtw:MiddleEastAndAsiaPacificSegmentMember2024-03-310000061986us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2024-01-012024-03-310000061986us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-03-310000061986mtw:EuropeAndAfricaSegmentMember2023-12-310000061986us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-01-012024-03-310000061986us-gaap:OperatingSegmentsMember2024-01-012024-03-3100000619862023-01-012023-03-310000061986us-gaap:ComputerEquipmentMember2023-12-310000061986mtw:OtherCountriesMember2023-01-012023-03-310000061986us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000061986us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310000061986us-gaap:OperatingSegmentsMember2023-01-012023-03-310000061986country:USus-gaap:PensionPlansDefinedBenefitMember2023-01-012023-03-310000061986us-gaap:TreasuryStockCommonMember2024-01-012024-03-310000061986us-gaap:LetterOfCreditMembermtw:GermanBorrowersMembermtw:ABLRevolvingCreditFacilityMember2019-03-250000061986mtw:AmericasSegmentMember2023-12-310000061986mtw:ABLRevolvingCreditFacilityMember2023-12-310000061986us-gaap:IndefinitelivedIntangibleAssetsMemberus-gaap:TrademarksAndTradeNamesMember2024-03-310000061986us-gaap:NondesignatedMemberus-gaap:OtherNonoperatingIncomeExpenseMember2024-01-012024-03-310000061986us-gaap:ForeignExchangeContractMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000061986us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310000061986us-gaap:MaterialReconcilingItemsMember2024-01-012024-03-310000061986us-gaap:FiniteLivedIntangibleAssetsMemberus-gaap:CustomerRelationshipsMember2023-12-310000061986us-gaap:OperatingSegmentsMembermtw:MiddleEastAndAsiaPacificSegmentMember2023-01-012023-03-3100000619862023-12-310000061986us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2024-01-012024-03-310000061986us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2024-03-310000061986us-gaap:ForeignExchangeContractMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000061986us-gaap:CommonStockMember2022-12-310000061986mtw:SeniorNotesDue2026Member2024-03-310000061986us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-03-310000061986mtw:ABLRevolvingCreditFacilityMember2019-03-250000061986us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-03-310000061986us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2024-01-012024-03-310000061986mtw:SeniorNotesDue2026Member2024-01-012024-03-310000061986mtw:AmericasSegmentMember2024-01-012024-03-310000061986us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-01-012023-03-310000061986us-gaap:AccumulatedTranslationAdjustmentMember2024-03-310000061986us-gaap:ForeignExchangeContractMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-03-310000061986mtw:AmericasSegmentMember2024-03-310000061986us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310000061986us-gaap:OperatingSegmentsMembermtw:MiddleEastAndAsiaPacificSegmentMember2024-01-012024-03-310000061986us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310000061986us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000061986us-gaap:AdditionalPaidInCapitalMember2023-03-310000061986us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-03-310000061986us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembermtw:ABLRevolvingCreditFacilityMember2024-01-012024-03-310000061986mtw:EquipmentsLeasedToOtherPartyMember2023-12-310000061986us-gaap:TreasuryStockCommonMember2023-12-310000061986us-gaap:MachineryAndEquipmentMember2024-03-310000061986us-gaap:FiniteLivedIntangibleAssetsMembermtw:OtherIntangiblesMember2024-03-310000061986us-gaap:RetainedEarningsMember2023-01-012023-03-310000061986us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310000061986us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000061986mtw:AlternativeBaseRateMembermtw:LesserThanToFiftyPercentOfAggregateCommitmentMembermtw:ABLRevolvingCreditFacilityMember2024-01-012024-03-310000061986us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-31iso4217:EURxbrli:purexbrli:sharesmtw:Segmentiso4217:USDxbrli:sharesiso4217:USD

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

img165350942_0.jpg 

FORM 10-Q

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2024

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 1-11978

 

The Manitowoc Company, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

 

Wisconsin

 

39-0448110

(State or other jurisdiction

 

(I.R.S. Employer

of incorporation or organization)

 

Identification Number)

 

11270 West Park Place

Suite 1000

 

 

Milwaukee, Wisconsin

 

53224

(Address of principal executive offices)

 

(Zip Code)

Registrant’s telephone number, including area code: (414) 760-4600

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

Common Stock, $.01 Par Value

 

MTW

 

New York Stock Exchange

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

 

 

 

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

As of March 31, 2024, the registrant had 35,540,950 shares of common stock, $.01 par value per share, outstanding.


 


 

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

THE MANITOWOC COMPANY, INC.

Condensed Consolidated Statements of Operations

For the three months ended March 31, 2024 and 2023

(Unaudited)

(In millions, except per share and share amounts)

 

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

Net sales

 

$

495.1

 

 

$

508.3

 

Cost of sales

 

 

402.6

 

 

 

402.0

 

Gross profit

 

 

92.5

 

 

 

106.3

 

Operating costs and expenses:

 

 

 

 

 

 

Engineering, selling, and administrative expenses

 

 

76.0

 

 

 

75.1

 

Amortization of intangible assets

 

 

0.7

 

 

 

1.0

 

Restructuring expense

 

 

0.6

 

 

 

 

Total operating costs and expenses

 

 

77.3

 

 

 

76.1

 

Operating income

 

 

15.2

 

 

 

30.2

 

Other income (expense):

 

 

 

 

 

 

Interest expense

 

 

(9.2

)

 

 

(8.1

)

Amortization of deferred financing fees

 

 

(0.3

)

 

 

(0.3

)

Other income (expense) - net

 

 

0.7

 

 

 

(1.1

)

Total other expense

 

 

(8.8

)

 

 

(9.5

)

Income before income taxes

 

 

6.4

 

 

 

20.7

 

Provision for income taxes

 

 

1.9

 

 

 

4.2

 

Net income

 

$

4.5

 

 

$

16.5

 

 

 

 

 

 

 

Per Share Data and Share Amounts

 

 

 

 

 

 

Basic net income per common share

 

$

0.13

 

 

$

0.47

 

 

 

 

 

 

 

Diluted net income per common share

 

$

0.12

 

 

$

0.46

 

 

 

 

 

 

 

Weighted average shares outstanding - basic

 

 

35,265,449

 

 

 

35,121,473

 

Weighted average shares outstanding - diluted

 

 

36,060,640

 

 

 

35,748,021

 

 

The accompanying notes are an integral part to these Condensed Consolidated Financial Statements.

 

2


 

THE MANITOWOC COMPANY, INC.

Condensed Consolidated Statements of Comprehensive Income (Loss)

For the three months ended March 31, 2024 and 2023

(Unaudited)

(In millions)

 

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

Net income

 

$

4.5

 

 

$

16.5

 

Other comprehensive income (loss), net of income tax:

 

 

 

 

 

 

Unrealized losses on derivatives, net of income tax
   provision of $
0.0 and $0.0, respectively

 

 

(1.6

)

 

 

(3.3

)

Employee pension and postretirement benefit income (expense), net of
   income tax provision of $
0.0 and $0.0, respectively

 

 

0.1

 

 

 

(1.0

)

Foreign currency translation adjustments, net of income tax benefit
   of $
0.6 and $0.2, respectively

 

 

(11.0

)

 

 

4.2

 

Total other comprehensive loss, net of income tax

 

 

(12.5

)

 

 

(0.1

)

Comprehensive income (loss)

 

$

(8.0

)

 

$

16.4

 

 

The accompanying notes are an integral part to these Condensed Consolidated Financial Statements.

3


 

THE MANITOWOC COMPANY, INC.

Condensed Consolidated Balance Sheets

As of March 31, 2024 and December 31, 2023

(Unaudited)

(In millions, except par value and share amounts)

 

 

 

March 31,
2024

 

 

December 31,
2023

 

Assets

 

 

 

 

 

 

Current Assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

31.5

 

 

$

34.4

 

Accounts receivable, less allowances of $5.9 and $6.1, respectively

 

 

290.3

 

 

 

278.8

 

Inventories - net

 

 

748.0

 

 

 

666.5

 

Notes receivable - net

 

 

5.7

 

 

 

6.7

 

Other current assets

 

 

43.9

 

 

 

46.6

 

Total current assets

 

 

1,119.4

 

 

 

1,033.0

 

Property, plant, and equipment - net

 

 

357.5

 

 

 

366.1

 

Operating lease right-of-use assets

 

 

58.8

 

 

 

59.7

 

Goodwill

 

 

78.7

 

 

 

79.6

 

Intangible assets - net

 

 

123.3

 

 

 

125.6

 

Other non-current assets

 

 

42.9

 

 

 

42.7

 

Total assets

 

$

1,780.6

 

 

$

1,706.7

 

Liabilities and Stockholders' Equity

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

 

Accounts payable and accrued expenses

 

$

509.4

 

 

$

457.4

 

Customer advances

 

 

20.3

 

 

 

19.2

 

Short-term borrowings and current portion of long-term debt

 

 

42.5

 

 

 

13.4

 

Product warranties

 

 

41.3

 

 

 

47.1

 

Other liabilities

 

 

18.7

 

 

 

26.2

 

Total current liabilities

 

 

632.2

 

 

 

563.3

 

Non-Current Liabilities:

 

 

 

 

 

 

Long-term debt

 

 

372.7

 

 

 

358.7

 

Operating lease liabilities

 

 

46.6

 

 

 

47.2

 

Deferred income taxes

 

 

7.4

 

 

 

7.5

 

Pension obligations

 

 

54.9

 

 

 

55.8

 

Postretirement health and other benefit obligations

 

 

5.4

 

 

 

5.6

 

Long-term deferred revenue

 

 

21.1

 

 

 

24.1

 

Other non-current liabilities

 

 

44.3

 

 

 

41.2

 

Total non-current liabilities

 

 

552.4

 

 

 

540.1

 

Commitments and contingencies (Note 17)

 

 

 

 

 

 

Stockholders' Equity:

 

 

 

 

 

 

Preferred stock (3,500,000 shares authorized of $.01 par value;
   
none outstanding)

 

 

 

 

 

 

Common stock (75,000,000 shares authorized, 40,793,983 shares issued,
   
35,540,950 and 35,094,993 shares outstanding, respectively)

 

 

0.4

 

 

 

0.4

 

Additional paid-in capital

 

 

608.5

 

 

 

613.1

 

Accumulated other comprehensive loss

 

 

(98.9

)

 

 

(86.4

)

Retained earnings

 

 

148.0

 

 

 

143.5

 

Treasury stock, at cost (5,253,033 and 5,698,990 shares, respectively)

 

 

(62.0

)

 

 

(67.3

)

Total stockholders' equity

 

 

596.0

 

 

 

603.3

 

Total liabilities and stockholders' equity

 

$

1,780.6

 

 

$

1,706.7

 

 

The accompanying notes are an integral part to these Condensed Consolidated Financial Statements.

4


 

THE MANITOWOC COMPANY, INC.

Condensed Consolidated Statements of Cash Flows

For the three months ended March 31, 2024 and 2023

(Unaudited)

(In millions)

 

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

Cash Flows from Operating Activities:

 

 

 

 

 

 

Net income

 

$

4.5

 

 

$

16.5

 

Adjustments to reconcile net income to cash provided by (used for) operating activities:

 

 

 

 

 

 

Depreciation expense

 

 

14.7

 

 

 

13.9

 

Amortization of intangible assets

 

 

0.7

 

 

 

1.0

 

Stock-based compensation expense

 

 

3.7

 

 

 

3.1

 

Amortization of deferred financing fees

 

 

0.3

 

 

 

0.3

 

Loss on sale of property, plant, and equipment

 

 

0.2

 

 

 

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

Accounts receivable

 

 

(15.3

)

 

 

17.1

 

Inventories

 

 

(89.1

)

 

 

(100.6

)

Notes receivable

 

 

1.5

 

 

 

1.7

 

Other assets

 

 

1.1

 

 

 

1.6

 

Accounts payable

 

 

56.6

 

 

 

56.2

 

Accrued expenses and other liabilities

 

 

(9.5

)

 

 

4.6

 

Net cash provided by (used for) operating activities

 

 

(30.6

)

 

 

15.4

 

Cash Flows from Investing Activities:

 

 

 

 

 

 

Capital expenditures

 

 

(12.2

)

 

 

(10.6

)

Proceeds from sale of fixed assets

 

 

0.2

 

 

 

2.0

 

Net cash used for investing activities

 

 

(12.0

)

 

 

(8.6

)

Cash Flows from Financing Activities:

 

 

 

 

 

 

Proceeds from (payments on) revolving credit facility - net

 

 

14.0

 

 

 

(10.0

)

Proceeds from (payments on) other debt - net

 

 

29.1

 

 

 

(1.9

)

Exercises of stock options

 

 

 

 

 

0.3

 

Common stock repurchases

 

 

 

 

 

(3.5

)

Other financing activities

 

 

(2.9

)

 

 

 

Net cash provided by (used for) financing activities

 

 

40.2

 

 

 

(15.1

)

Effect of exchange rate changes on cash and cash equivalents

 

 

(0.5

)

 

 

0.4

 

Net decrease in cash and cash equivalents

 

 

(2.9

)

 

 

(7.9

)

Cash and cash equivalents at beginning of period

 

 

34.4

 

 

 

64.4

 

Cash and cash equivalents at end of period

 

$

31.5

 

 

$

56.5

 

Supplemental Cash Flow Information

 

 

 

 

 

 

Interest paid

 

$

2.1

 

 

$

1.3

 

Income taxes paid

 

 

1.8

 

 

 

1.7

 

 

The accompanying notes are an integral part to these Condensed Consolidated Financial Statements.

5


 

THE MANITOWOC COMPANY, INC.

Condensed Consolidated Statements of Equity

For the three months ended March 31, 2024 and 2023

(Unaudited)

(In millions)

 

 

 

March 31,
2024

 

 

March 31,
2023

 

Common Stock - Par Value

 

 

 

 

 

 

Balance at beginning of period

 

$

0.4

 

 

$

0.4

 

Balance at end of period

 

$

0.4

 

 

$

0.4

 

Additional Paid-in Capital

 

 

 

 

 

 

Balance at beginning of period

 

$

613.1

 

 

$

606.7

 

Stock compensation plans

 

 

(8.3

)

 

 

(4.0

)

Stock-based compensation expense

 

 

3.7

 

 

 

3.1

 

Balance at end of period

 

$

608.5

 

 

$

605.8

 

Accumulated Other Comprehensive Loss

 

 

 

 

 

 

Balance at beginning of period

 

$

(86.4

)

 

$

(107.9

)

Other comprehensive loss

 

 

(12.5

)

 

 

(0.1

)

Balance at end of period

 

$

(98.9

)

 

$

(108.0

)

Retained Earnings

 

 

 

 

 

 

Balance at beginning of period

 

$

143.5

 

 

$

104.3

 

Net income

 

 

4.5

 

 

 

16.5

 

Balance at end of period

 

$

148.0

 

 

$

120.8

 

Treasury Stock

 

 

 

 

 

 

Balance at beginning of period

 

$

(67.3

)

 

$

(65.7

)

Stock compensation plans

 

 

5.3

 

 

 

3.0

 

Common stock repurchases

 

 

 

 

 

(3.5

)

Balance at end of period

 

$

(62.0

)

 

$

(66.2

)

Total stockholders' equity

 

$

596.0

 

 

$

552.8

 

 

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

 

 

6


 

THE MANITOWOC COMPANY, INC.

Notes to Unaudited Condensed Consolidated Financial Statements

For the three months ended March 31, 2024 and 2023

1. Company and Basis of Presentation

The Manitowoc Company, Inc. (“Manitowoc” or the “Company”) was founded in 1902 and has over a 120-year tradition of providing high-quality, customer-focused products and support services to its markets. Headquartered in Milwaukee, Wisconsin, United States, Manitowoc is one of the world's leading providers of engineered lifting solutions. Manitowoc, through its wholly-owned subsidiaries, designs, manufactures, markets, distributes, and supports comprehensive product lines of mobile hydraulic cranes, lattice-boom crawler cranes, boom trucks, and tower cranes under the Aspen Equipment, Grove, Manitowoc, MGX Equipment Services, National Crane, Potain, and Shuttlelift brand names. The Company serves a wide variety of customers, including dealers, rental companies, contractors, and government entities, across the petrochemical, industrial, commercial construction, power and utilities, infrastructure and residential construction end markets. Due to the ongoing and predictable maintenance needed by cranes, as well as the high cost of crane downtime, Manitowoc’s aftermarket support operations provide the Company with a consistent stream of recurring revenue.

The Company has three reportable segments, the Americas segment, the Europe and Africa ("EURAF") segment and Middle East and Asia Pacific (“MEAP”) segment. The Americas segment includes the North America and South America continents. The EURAF reporting segment includes the Europe and Africa continents, excluding the Middle East region. The MEAP reporting segment includes the Asia and Australia continents and the Middle East region. The segments were identified using the “management approach,” which designates the internal organization that is used by management for making operating decisions and assessing performance. Refer to Note 16, “Segments,” for additional information.

In the opinion of management, the accompanying unaudited Condensed Consolidated Financial Statements contain all adjustments necessary for a fair statement of the results of operations for the three months ended March 31, 2024 and 2023, the cash flows for the same three-month periods, and the financial position as of March 31, 2024 and December 31, 2023, and except as otherwise discussed, such adjustments consist of only those of a normal recurring nature. The audited balance sheet as of December 31, 2023, was derived from the audited annual financial statements. The interim results are not necessarily indicative of results for a full year and do not contain information included in the Company’s annual consolidated financial statements and notes for the year ended December 31, 2023. Certain information and footnote disclosures, normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”), have been condensed or omitted pursuant to Securities and Exchange Commission rules and regulations dealing with interim financial statements. However, the Company believes that the disclosures made in the Condensed Consolidated Financial Statements included herein are adequate to make the information presented not misleading. It is suggested that these financial statements be read in conjunction with the financial statements and the notes thereto included in the Company’s latest annual report on Form 10-K.

All amounts, except per share data and share amounts, are in millions throughout the tables in these notes unless otherwise indicated.

2. Recent Accounting Changes and Pronouncements

In November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2023-07, "Segment Reporting - Improvements to Reportable Segments Disclosures.” The amendments in this ASU improve reportable segment disclosure requirements, primarily through enhanced footnote disclosures about significant segment expenses. The standard is effective for annual periods beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company does not expect the adoption of this ASU will have a material impact on its consolidated financial statements.

In December 2023, the FASB issued ASU No. 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” The amendments in this ASU enhance the transparency and decision usefulness of income tax disclosures. The standard is effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The Company does not expect the adoption of this ASU will have a material impact on its consolidated financial statements.

7


 

3. Net Sales

The Company defers revenue when cash payments are received in advance of satisfying the related performance obligation. These amounts are recorded as customer advances in the Condensed Consolidated Balance Sheets. The table below shows the change in the customer advances balance for the three months ended March 31, 2024 and 2023.

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

Balance at beginning of period

 

$

19.2

 

 

$

21.9

 

Cash received in advance of satisfying
   performance obligations

 

 

39.1

 

 

 

34.4

 

Revenue recognized

 

 

(37.7

)

 

 

(32.4

)

Currency translation

 

 

(0.3

)

 

 

0.1

 

Balance at end of period

 

$

20.3

 

 

$

24.0

 

Disaggregation of the Company’s revenue sources are disclosed in Note 16, “Segments.”

4. Fair Value of Financial Instruments

The following table sets forth the Company’s financial assets and liabilities related to foreign currency exchange contracts ("FX Forward Contracts") and The Manitowoc Company, Inc. Deferred Compensation Plan (the "Deferred Compensation Plan") that were accounted for at fair value as of March 31, 2024 and December 31, 2023.

 

 

Fair Value as of March 31, 2024

 

 

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 

Recognized Location

Current Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FX Forward Contracts

 

$

 

 

$

0.3

 

 

$

 

 

$

0.3

 

 

 Other current assets

Deferred Compensation Plan - Program B

 

 

8.9

 

 

 

 

 

 

 

 

 

8.9

 

 

 Other non-current assets

Total current assets at fair value

 

$

8.9

 

 

$

0.3

 

 

$

 

 

$

9.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FX Forward Contracts

 

$

 

 

$

1.1

 

 

$

 

 

$

1.1

 

 

 Accounts payable and
   accrued expenses

 

 

 

Fair Value as of December 31, 2023

 

 

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 

Recognized Location

Current Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FX Forward Contracts

 

$

 

 

$

1.6

 

 

$

 

 

$

1.6

 

 

 Other current assets

Deferred Compensation Plan - Program B

 

 

8.1

 

 

 

 

 

 

 

 

 

8.1

 

 

 Other non-current assets

Total current assets at fair value

 

$

8.1

 

 

$

1.6

 

 

$

 

 

$

9.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FX Forward Contracts

 

$

 

 

$

0.6

 

 

$

 

 

$

0.6

 

 

 Accounts payable and
   accrued expenses

The fair value of the $300.0 million senior secured second lien notes due on April 1, 2026, with an annual coupon rate of 9.000% (the “2026 Notes”), was approximately $300.2 million as of March 31, 2024 and $302.7 million as of December 31, 2023. Refer to Note 10, “Debt,” for a description of the 2026 Notes and the related carrying value.

The Company endeavors to utilize the best available information in measuring fair value. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company estimates the fair value of its 2026 Notes based on quoted market prices of the instruments; because these markets are typically actively traded, the liabilities are classified as Level 1 within the valuation hierarchy. The carrying values of cash and cash equivalents, accounts receivable, accounts payable and short-term variable debt, including any amounts outstanding under the

8


 

Company’s revolving credit facility, approximate fair value, without being discounted as of March 31, 2024, due to the short-term nature of these instruments.

FX Forward Contracts are valued through an independent valuation source which uses an industry standard data provider, with resulting valuations periodically validated through third-party or counterparty quotes. As such, these derivative instruments are classified within Level 2. Refer to Note 5, “Derivative Financial Instruments,” for additional information.

The Deferred Compensation Plan utilizes a rabbi trust to hold assets intended to satisfy the Company’s corresponding future benefit obligations. The plan assets and corresponding obligations for Program B under the Deferred Compensation Plan are classified within Level 1.

5. Derivative Financial Instruments

The Company’s risk management objective is to ensure that business exposures to risks are minimized using the most effective and efficient methods to eliminate, reduce, or transfer such exposures. Operating decisions consider these associated risks and, whenever possible, transactions are structured to avoid or mitigate these risks.

From time to time, the Company enters into FX Forward Contracts to manage the exposure on forecasted transactions denominated in non-functional currencies and to manage the risk of transaction gains and losses associated with assets/liabilities in currencies other than the functional currency of certain subsidiaries. Certain of these FX Forward Contracts are designated as cash flow hedges. To the extent these derivatives are effective in offsetting the variability of the hedged cash flows, changes in the derivatives’ fair value are not included in current earnings but are included in accumulated other comprehensive income (loss) ("AOCI"). These changes in fair value are reclassified into earnings as a component of cost of sales, as applicable, when the forecasted transaction impacts earnings. In addition, if the forecasted transaction is no longer probable, the cumulative change in the derivatives’ fair value is recorded as a component of other income (expense) – net in the period in which the transaction is no longer considered probable of occurring. No amounts were recorded related to forecasted transactions no longer being probable during the three months ended March 31, 2024 and 2023.

The Company had FX Forward Contracts with aggregate notional amounts of $124.8 million and $140.1 million in U.S. dollar equivalent as of March 31, 2024 and December 31, 2023, respectively. The aggregate notional amount outstanding as of March 31, 2024, is scheduled to mature within one year. The FX Forward Contracts purchased are denominated in various foreign currencies. Net unrealized gains (losses), net of income tax, recorded in AOCI were $(0.3) million and $1.3 million as of March 31, 2024 and December 31, 2023, respectively.

The net gains (losses) recorded in the Condensed Consolidated Statements of Operations for FX Forward Contracts for the three months ended March 31, 2024 and 2023 are summarized as follows:

 

 

 

 

Three Months Ended
March 31,

 

 

 

Recognized Location

 

2024

 

 

2023

 

Designated

 

Cost of sales

 

$

(0.9

)

 

$

3.4

 

Non-Designated

 

Other income (expense) - net

 

$

1.4

 

 

$

(2.3

)

 

6. Inventories

The components of inventories as of March 31, 2024 and December 31, 2023 are summarized as follows:

 

 

March 31,
2024

 

 

December 31,
2023

 

Raw materials

 

$

203.4

 

 

$

164.7

 

Work-in-process

 

 

154.0

 

 

 

111.3

 

Finished goods

 

 

390.6

 

 

 

390.5

 

Total Inventories

 

$

748.0

 

 

$

666.5

 

 

9


 

 

7. Property, Plant, and Equipment

The components of property, plant, and equipment as of March 31, 2024 and December 31, 2023 are summarized as follows:

 

 

March 31,
2024

 

 

December 31,
2023

 

Land

 

$

14.7

 

 

$

14.9

 

Building and improvements

 

 

199.6

 

 

 

201.5

 

Machinery, equipment, and tooling

 

 

320.7

 

 

 

318.4

 

Furniture and fixtures

 

 

13.3

 

 

 

13.8

 

Computer hardware and software

 

 

134.8

 

 

 

135.8

 

Rental cranes

 

 

199.3

 

 

 

201.9

 

Construction in progress

 

 

6.7

 

 

 

7.2

 

Total cost

 

 

889.1

 

 

 

893.5

 

Less: accumulated depreciation

 

 

(531.6

)

 

 

(527.4

)

Property, plant, and equipment - net

 

$

357.5

 

 

$

366.1

 

Property, plant, and equipment is depreciated over the estimated useful life of the asset using the straight-line depreciation method for financial reporting and accelerated methods for income tax purposes.

Additions to property, plant, and equipment included in accounts payable and accrued expenses in the Condensed Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023 were $5.8 million and $7.0 million, respectively.

Assets Held for Sale

As of March 31, 2024 and December 31, 2023, the Company had $3.5 million and $3.0 million, respectively, of property, plant, and equipment classified as assets held for sale in other current assets in the Condensed Consolidated Balance Sheets. This amount relates to a manufacturing building and land in Fanzeres, Portugal.

8. Goodwill and Intangible Assets

The changes in the carrying amount of goodwill for the three months ended March 31, 2024 is summarized as follows:

 

 

Americas

 

 

MEAP

 

 

Consolidated

 

Balance as of December 31, 2023

 

$

14.4

 

 

$

65.2

 

 

$

79.6

 

Foreign currency impact

 

 

 

 

 

(0.9

)

 

 

(0.9

)

Balance as of March 31, 2024

 

$

14.4

 

 

$

64.3

 

 

$

78.7

 

The gross carrying amount, accumulated impairment and net book value of the Company's goodwill balances by reportable segment as of March 31, 2024 and December 31, 2023, are summarized as follows:

 

 

March 31, 2024

 

 

December 31, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Carrying Amount

 

 

Accumulated Impairment Amount

 

 

Net Book Value

 

 

Gross Carrying Amount

 

 

Accumulated Impairment Amount

 

Net Book Value

 

Americas

 

$

180.9

 

 

$

(166.5

)

 

$

14.4

 

 

$

180.9

 

 

$

(166.5

)

$

14.4

 

EURAF

 

 

82.2

 

 

 

(82.2

)

 

 

 

 

 

82.2

 

 

 

(82.2

)

 

 

MEAP

 

 

64.3

 

 

 

 

 

 

64.3

 

 

 

65.2

 

 

 

 

 

65.2

 

Total

 

$

327.4

 

 

$

(248.7

)

 

$

78.7

 

 

$

328.3

 

 

$

(248.7

)

$

79.6

 

The Company performs its annual goodwill impairment test during the fourth quarter, or more frequently if events or changes in circumstances indicate that there might be an impairment of the asset. The Company will continue to monitor changes in circumstances and test more frequently if those changes indicate that assets might be impaired. The Company determined there was no triggering event for the three months ended March 31, 2024.

10


 

The gross carrying amount, accumulated amortization, and net book value of the Company’s intangible assets other than goodwill as of March 31, 2024 and December 31, 2023, are summarized as follows:

 

 

March 31, 2024

 

 

December 31, 2023

 

 

 

Gross
Carrying
Amount

 

 

Accumulated
Amortization
Amount

 

 

Net
Book
Value

 

 

Gross
Carrying
Amount

 

 

Accumulated
Amortization
Amount

 

 

Net
Book
Value

 

Definite lived intangible assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Customer relationships

 

$

26.4

 

 

$

(12.0

)

 

$

14.4

 

 

$

26.5

 

 

$

(11.6

)

 

$

14.9

 

Patents

 

 

28.8

 

 

 

(28.4

)

 

 

0.4

 

 

 

29.2

 

 

 

(28.8

)

 

 

0.4

 

Noncompetition agreements

 

 

4.2

 

 

 

(2.2

)

 

 

2.0

 

 

 

4.2

 

 

 

(2.0

)

 

 

2.2

 

Trademarks and tradenames

 

 

2.2

 

 

 

(1.1

)

 

 

1.1

 

 

 

2.2

 

 

 

(1.0

)

 

 

1.2

 

Other intangibles

 

 

0.6

 

 

 

(0.6

)

 

 

 

 

 

0.7

 

 

 

(0.7

)

 

 

 

Total

 

$

62.2

 

 

$

(44.3

)

 

$

17.9

 

 

$

62.8

 

 

$

(44.1

)

 

$

18.7

 

Indefinite-lived intangible assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trademarks and tradenames

 

$

91.3

 

 

$

 

 

$

91.3

 

 

$

92.6

 

 

$

 

 

$

92.6

 

Distribution network

 

 

14.1

 

 

 

 

 

 

14.1

 

 

 

14.3

 

 

 

 

 

 

14.3

 

Total

 

 

105.4

 

 

 

 

 

 

105.4

 

 

 

106.9

 

 

 

 

 

 

106.9

 

Total intangible assets

 

$

167.6

 

 

$

(44.3

)

 

$

123.3

 

 

$

169.7

 

 

$

(44.1

)

 

$

125.6

 

The Company performs its annual indefinite-lived intangible assets impairment testing during the fourth quarter, or more frequently if events or changes in circumstances indicate that there might be an impairment of the asset. The Company will continue to monitor changes in circumstances and test more frequently if those changes indicate that assets might be impaired. The Company determined there was no triggering event for the three months ended March 31, 2024.

Definite lived intangible assets and long-lived assets are subject to impairment testing whenever events or circumstances indicate that the carrying value of the assets may not be recoverable. The Company determined there was no triggering event for the three months ended March 31, 2024.

Other intangible assets with definite lives are amortized over their estimated useful lives. Amortization expense for the three months ended March 31, 2024 and 2023 was $0.7 million and $1.0 million, respectively.

9. Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses as of March 31, 2024 and December 31, 2023 are summarized as follows:

 

 

 

March 31, 2024

 

 

December 31, 2023

 

Trade accounts payable

 

$

306.9

 

 

$

254.7

 

Employee-related expenses

 

 

47.0

 

 

 

57.9

 

Accrued vacation

 

 

24.7

 

 

 

23.7

 

Miscellaneous accrued expenses

 

 

130.8

 

 

 

121.1

 

Total accounts payable and accrued expenses

 

$

509.4

 

 

$

457.4

 

 

10. Debt

Outstanding debt as of March 31, 2024 and December 31, 2023 is summarized as follows:

 

 

March 31, 2024

 

 

December 31, 2023

 

Borrowings under senior secured asset-based
   revolving credit facility

 

$

74.0

 

 

$

60.0

 

Senior secured second lien notes due 2026

 

 

300.0

 

 

 

300.0

 

Other debt

 

 

42.7

 

 

 

13.7

 

Deferred financing costs

 

 

(1.5

)

 

 

(1.6

)

Total debt

 

 

415.2

 

 

 

372.1

 

Short-term borrowings and current portion of long-term
   debt

 

 

(42.5

)

 

 

(13.4

)

Long-term debt

 

$

372.7

 

 

$

358.7

 

 

11


 

On March 25, 2019, the Company and certain subsidiaries of the Company (the “Loan Parties”) entered into a credit agreement (the “ABL Credit Agreement”) with JP Morgan Chase Bank, N.A. as administrative and collateral agent, and certain financial institutions party thereto as lenders, providing for a senior secured asset-based revolving credit facility (the “ABL Revolving Credit Facility”) of up to $275.0 million. The borrowing capacity under the ABL Revolving Credit Facility is based on the value of inventory, accounts receivable and certain fixed assets of the Loan Parties. The Loan Parties’ obligations under the ABL Revolving Credit Facility are secured on a first-priority basis, subject to certain exceptions and permitted liens, by substantially all of the personal property and fee-owned real property of the Loan Parties. The liens securing the ABL Revolving Credit Facility are senior in priority to the second-priority liens securing the obligations under the 2026 Notes and the related guarantees. The ABL Revolving Credit Facility includes a $75.0 million letter of credit sub-facility, $10.0 million of which is available to the Company’s German subsidiary that is a borrower under the ABL Revolving Credit Facility.

On June 17, 2021, the Company amended the ABL Credit Agreement to adjust certain negative covenants which reduced restrictions on the Company’s ability to expand its rental business. On May 19, 2022, the Company further amended the ABL Credit Agreement to (i) extend the maturity date to May 19, 2027 (subject to a springing maturity date of December 30, 2025 if the 2026 Notes have not been repaid in full or refinanced prior to December 30, 2025), (ii) permit the inclusion, subject to certain limitations, of the crane rental assets of certain subsidiaries in the borrowing base used to calculate availability under the ABL Credit Agreement, (iii) permit separate financing of crane rental assets not included in the borrowing base and (iv) replace U.S. dollar London Inter-bank Offered Rate with interest rates based on the secured overnight financing rate plus a credit spread adjustment (“SOFR”).

Borrowings under the ABL Revolving Credit Facility bear interest at a variable rate using either the Alternative Base Rate or SOFR plus the spread set forth below. The variable interest rate is based upon the average availability as of the most recent determination date as follows:

Average quarterly availability

Alternative base rate spread

SOFR spread

≥ 50% of Aggregate Commitment

0.25%

1.25%

< 50% of Aggregate Commitment

0.50%

1.50%

As of March 31, 2024 and December 31, 2023, the Company had borrowings on the ABL Revolving Credit Facility of $74.0 million and $60.0 million, respectively. As of March 31, 2024, the spreads for SOFR and Eurodollar, and Alternative Base Rate borrowings were 1.25% and 0.25%, respectively, with excess availability of approximately $197.6 million, which represents revolver borrowing capacity of $275.0 million less $74.0 million of borrowings outstanding and $3.4 million of U.S. letters of credit outstanding.

As of March 31, 2024, the Company had $42.7 million of other indebtedness outstanding that has a weighted-average interest rate of approximately 5.4%. This debt includes balances on local credit lines, overdraft facilities, and other financing arrangements.

On March 25, 2019, the Company and certain of its subsidiaries entered into an indenture with U.S. Bank National Association as trustee and notes collateral agent, pursuant to which the Company issued $300.0 million aggregate principal amount of the 2026 Notes with an annual coupon rate of 9.000%. Interest on the 2026 Notes is payable in cash semi-annually in arrears on April 1 and October 1 of each year. The 2026 Notes are fully and unconditionally guaranteed on a senior secured second lien basis, jointly and severally, by each of the Company’s existing and future domestic subsidiaries that is either a guarantor or a borrower under the ABL Revolving Credit Facility or that guarantees certain other debt of the Company or a guarantor. The 2026 Notes and the related guarantees are secured on a second-priority basis, subject to certain exceptions and permitted liens, by pledges of capital stock and other equity interests and other security interests in substantially all of the personal property and fee-owned real property of the Company and of the guarantors that secure obligations under the ABL Revolving Credit Facility.

Both the ABL Revolving Credit Facility and the 2026 Notes include customary covenants which include, without limitation, restrictions on, the Company’s ability and the ability of the Company’s restricted subsidiaries to incur, assume or guarantee additional debt or issue certain preferred shares, pay dividends on or make other distributions in respect of the Company’s capital stock or make other restricted payments, make certain investments, sell or transfer certain assets, create liens on certain assets to secure debt, consolidate, merge, sell, or otherwise dispose of all or substantially all of the Company’s assets, enter into certain transactions with affiliates and designate the Company’s subsidiaries as unrestricted. Both the ABL Revolving Credit Facility and the 2026 Notes also include customary events of default. The ABL Revolving Credit Facility has customary representations and warranties including, as a condition to borrowing, that all such representations and warranties are true and

12


 

correct, in all material respects, on the date of the borrowing, including representations as to no material adverse change in the Company’s business or financial condition since December 31, 2018.

Additionally, the ABL Revolving Credit Facility contains a covenant requiring the Company to maintain a minimum fixed charge coverage ratio under certain circumstances set forth in the ABL Credit Agreement.

As of March 31, 2024, the Company was in compliance with all affirmative and negative covenants in its debt instruments, inclusive of the financial covenants pertaining to the ABL Revolving Credit Facility and 2026 Notes. Based upon management’s current plans and outlook, the Company believes it will be able to comply with these covenants during the subsequent twelve months.

11. Accounts Receivable Factoring

The Company has two non-U.S. accounts receivable financing programs with no maximum availability. Transactions under the non-U.S. programs were accounted for as sales in accordance with Accounting Standards Codification (“ASC”) Topic 860, “Transfers and Servicing.” Under these financing programs, the Company has the ability to sell eligible receivables up to the maximum limit.

For the three months ended March 31, 2024 and 2023, cash proceeds from the factoring of accounts receivable qualifying as sales were $36.0 million.

Financing charges incurred from the factoring of accounts receivable qualifying as sales for the three months ended March 31, 2024 and 2023 were immaterial.

12. Income Taxes

 

The Company’s income before income taxes include income from both U.S. and foreign jurisdictions. The annual effective tax rate varies from the U.S. federal statutory rate of 21% due to results of foreign operations that are subject to income taxes at different statutory rates. In addition, tax expense is impacted by losses in jurisdictions where no tax benefit can be realized.

For the three months ended March 31, 2024 and 2023, the Company recorded a provision for income taxes of $1.9 million and $4.2 million, respectively.

As of March 31, 2024 and December 31, 2023, the Company’s unrecognized tax benefits, excluding interest and penalties, were $9.2 million and $9.1 million, respectively.

13. Net Income Per Common Share

The following is a reconciliation of the weighted average shares outstanding used to compute basic and diluted net income per common share:

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

Basic weighted average common shares outstanding

 

 

35,265,449

 

 

 

35,121,473

 

Effect of dilutive securities - equity
   compensation awards

 

 

795,191

 

 

 

626,548

 

Diluted weighted average common shares outstanding

 

 

36,060,640

 

 

 

35,748,021

 

Equity compensation awards for which total employee proceeds from exercise exceed the average fair value of the same equity incentive instrument over the period have an anti-dilutive effect on earnings per share during periods with net income, and accordingly, are excluded from diluted weighted average common shares outstanding. Anti-dilutive equity instruments of 497,801 and 682,930 common shares were excluded from the computation of diluted net earnings per share for the three months ended March 31, 2024 and 2023, respectively.

No cash dividends were declared or paid during the three months ended March 31, 2024 and 2023.

13


 

14. Equity

Authorized capital consists of 75.0 million shares of $0.01 par value common stock and 3.5 million shares of $0.01 par value preferred stock. None of the preferred shares have been issued.

As of March 31, 2024, the Company has $35.0 million remaining under an authorization from the Board of Directors to purchase up to $35.0 million of the Company’s common stock at management’s discretion. The Company’s share repurchase program purchases shares in the open market to offset stock-based awards issued in conjunction with the Company’s 2013 Omnibus Incentive Plan.

A reconciliation of the changes in accumulated other comprehensive income (loss), net of income tax, by component for the three months ended March 31, 2024 and 2023 are summarized as follows:

 

 

Cash Flow Hedges

 

 

Pension &
Postretirement

 

 

Foreign Currency
Translation

 

 

Total

 

Balance as of December 31, 2022

 

$

5.4

 

 

$

(15.3

)

 

$

(98.0

)

 

$

(107.9

)

Other comprehensive income (loss) before
   reclassifications

 

 

0.1

 

 

 

(1.7

)

 

 

4.2

 

 

 

2.6

 

Amounts reclassified from accumulated other
   comprehensive income (loss)

 

 

(3.4

)

 

 

0.7

 

 

 

 

 

 

(2.7

)

Net other comprehensive income (loss)

 

 

(3.3

)

 

 

(1.0

)

 

 

4.2

 

 

 

(0.1

)

Balance as of March 31, 2023

 

$

2.1

 

 

$

(16.3

)

 

$

(93.8

)

 

$

(108.0

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of December 31, 2023

 

$

1.3

 

 

$

(10.3

)

 

$

(77.4

)

 

$

(86.4

)

Other comprehensive loss before
   reclassifications

 

 

(2.5

)

 

 

 

 

 

(11.0

)

 

 

(13.5

)

Amounts reclassified from accumulated other
   comprehensive income (loss)

 

 

0.9

 

 

 

0.1

 

 

 

 

 

 

1.0

 

Net other comprehensive income (loss)

 

 

(1.6

)

 

 

0.1

 

 

 

(11.0

)

 

 

(12.5

)

Balance as of March 31, 2024

 

$

(0.3

)

 

$

(10.2

)

 

$

(88.4

)

 

$

(98.9

)

A reconciliation of the reclassifications from accumulated other comprehensive loss, net of income tax, for the three months ended March 31, 2024 and 2023 are summarized as follows:

 

 

Amount Reclassified from Accumulated Other Comprehensive Loss

 

 

 

 

 

Three Months Ended March 31,
2024

 

 

Three Months Ended March 31,
2023

 

 

Recognized
Location

Gains (losses) on cash flow hedges

 

 

 

 

 

 

 

 

FX Forward Contracts

 

$

(0.9

)

 

$

3.4

 

 

Cost of sales

Total before income taxes

 

 

(0.9

)

 

 

3.4

 

 

 

Provision for income taxes

 

 

 

 

 

 

 

 

Total, net of income taxes

 

$

(0.9

)

 

$

3.4

 

 

 

Amortization of pension and
   postretirement items

 

 

 

 

 

 

 

 

Actuarial losses

 

$

(0.1

)

 

$

(1.0

)

(a)

Other income (expense) - net

Amortization of prior service cost

 

 

 

 

 

0.3

 

(a)

Other income (expense) - net

Total before income taxes

 

 

(0.1

)

 

 

(0.7

)

 

 

Provision for income taxes

 

 

 

 

 

 

 

 

Total, net of income taxes

 

$

(0.1

)

 

$

(0.7

)

 

 

 

 

 

 

 

 

 

 

 

Total reclassifications for the period,
   net of income taxes

 

$

(1.0

)

 

$

2.7

 

 

 

(a) These accumulated other comprehensive income (loss) components are components of net periodic pension cost (refer to Note 19, “Employee Benefit Plans,” for further details)

14


 

15. Stock-Based Compensation

Equity compensation awards may be granted to certain eligible employees or non-employee directors. A detailed description of the awards granted prior to 2024 is included in the Company’s 2023 Annual Report on Form 10-K. The total number of shares of the Company’s common stock available for awards under the Company’s 2013 Omnibus Incentive Plan is 7,477,395 shares. The total number of shares of the Company’s common stock still available for issuance as of March 31, 2024 is 2,338,858 shares.

Stock-based compensation expense was $3.7 million for the three months ended March 31, 2024 and $3.1 million for the three months ended March 31, 2023. The Company reports stock-based compensation expense within engineering, selling, and administrative expenses in the Condensed Consolidated Statements of Operations. The Company recognizes stock-based compensation expense over the award’s vesting period, subject to the retirement, death or disability provisions of the 2013 Omnibus Incentive Plan.

The Company granted 443,019 and 478,411 restricted stock units inclusive of 78,894 and 77,576 director awards during the three months ended March 31, 2024 and 2023, respectively. The restricted stock units granted to employees vest in three annual increments over a three-year period beginning on the grant date and director awards vest immediately on the grant date.

A total of 365,174 and 233,409 performance shares units were granted by the Company to employees during the three months ended March 31, 2024 and 2023, respectively. Performance share units vest after three years and are earned based on the extent to which performance goals are met over the applicable performance period. The performance goals and the applicable performance period vary for each grant year.

The performance goals for the performance share units granted in 2024 are weighted 60% on the 3-year average of the Company’s adjusted return on invested capital ("Adjusted ROIC") percentage from 2024 to 2026 and 40% on cumulative non-new machine sales from January 1, 2024 through December 31, 2026. The Company defines non-new machine sales as parts sales, used crane sales, rental revenue, service revenue and other revenue. The 2024 performance share units include a +/-20% modifier weighted on total shareholder return relative to a defined peer group of companies during the three-year performance period, not to exceed 200% of target shares granted.

The performance goals for the performance share units granted in 2023 are weighted 60% on the 3-year average of the Company’s adjusted EBITDA percentage from 2023 to 2025 and 40% on cumulative non-new machine sales from January 1, 2023 through December 31, 2025. The 2023 performance share units include a +/-20% modifier weighted on total shareholder return relative to a defined peer group of companies during the three-year performance period, not to exceed 200% of target shares granted.

16. Segments

The Company reports segment information based on the “management” approach. The management approach designates the internal reporting used by the Chief Executive Officer, who is also the Company’s Chief Operating Decision Maker (“CODM”), for making decisions about the allocation of resources and assessing performance as the source of the Company’s reportable operating segments.

The Company has three reportable segments: Americas, EURAF, and MEAP.

The CODM evaluates the performance of its reportable segments based on net sales and operating income. Segment net sales are recognized in the geographic region the product is sold. Operating income for each segment includes net sales to third parties, cost of sales directly attributable to the segment, and operating expenses directly attributable to the segment. Manufacturing variances generated within each operating segment are maintained in each segment’s operating income. Operating income for each segment excludes other income and expense and certain expenses managed outside the operating segments. Costs excluded from segment operating income include various corporate expenses such as stock-based compensation expense, income taxes, nonrecurring charges and other separately managed general and administrative costs. The Company does not include intercompany sales between segments for management reporting purposes. The Company’s operating segments were identified as its reportable segments. The CODM does not evaluate performance of the reportable segments based on total assets.

15


 

The following table shows information by reportable segment for the three months ended March 31, 2024 and 2023:

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

Net Sales

 

 

 

 

 

 

Americas

 

$

283.2

 

 

$

264.4

 

EURAF

 

 

143.0

 

 

 

178.2

 

MEAP

 

 

68.9

 

 

 

65.7

 

Total

 

$

495.1

 

 

$

508.3

 

Segment Operating Income (Loss)

 

 

 

 

 

 

Americas

 

$

29.5

 

 

$

28.5

 

EURAF

 

 

(11.8

)

 

 

3.6

 

MEAP

 

 

8.2

 

 

 

8.6

 

Total

 

$

25.9

 

 

$

40.7

 

Depreciation

 

 

 

 

 

 

Americas

 

$

7.3

 

 

$

7.2

 

EURAF

 

 

5.9

 

 

 

5.4

 

MEAP

 

 

0.8

 

 

 

0.6

 

Corporate

 

 

0.7

 

 

 

0.7

 

Total

 

$

14.7

 

 

$

13.9

 

Capital Expenditures

 

 

 

 

 

 

Americas

 

$

4.2

 

 

$

4.4

 

EURAF

 

 

7.2

 

 

 

4.7

 

MEAP

 

 

0.8

 

 

 

1.5

 

Corporate

 

 

 

 

 

 

Total

 

$

12.2

 

 

$

10.6

 

A reconciliation of the Company’s segment operating income to operating income in the Condensed Consolidated Statements of Operations for the three months ended March 31, 2024 and 2023 are summarized as follows:

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

Segment operating income

 

$

25.9

 

 

$

40.7

 

Unallocated corporate expenses

 

 

(10.7

)

 

 

(10.4

)

Unallocated restructuring expense

 

 

 

 

 

(0.1

)

Total operating income

 

$

15.2

 

 

$

30.2

 

Net sales by geographic area for the three months ended March 31, 2024 and 2023 are summarized as follows:

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

United States

 

$

249.2

 

 

$

213.8

 

Europe

 

 

138.2

 

 

 

174.4

 

Other

 

 

107.7

 

 

 

120.1

 

Total net sales

 

$

495.1

 

 

$

508.3

 

New machine and non-new machine sales for the three months ended March 31, 2024 and 2023 are summarized as follows:

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

New machine sales

 

$

349.9

 

 

$

357.3

 

Non-new machine sales

 

 

145.2

 

 

 

151.0

 

Total net sales

 

$

495.1

 

 

$

508.3

 

 

16


 

17. Commitments and Contingencies

The Company is subject to various legal proceedings and claims that have arisen in the ordinary course of business which have not been fully resolved. The outcome of any litigation is inherently uncertain. When a loss related to a legal proceeding or claim is probable and reasonably estimable, the Company accrues its best estimate for the ultimate resolution of the matter.

As of March 31, 2024, various product-related lawsuits were pending. To the extent permitted under applicable law, all of these lawsuits are insured with self-insurance retention levels. The Company’s self-insurance retention levels have varied over the last 10 years. As of March 31, 2024, the largest self-insured retention level for new occurrences currently maintained by the Company is $3.0 million per occurrence and applies to product liability claims arising in North America.

As of March 31, 2024, current and long-term product liability reserves were $4.1 million and $5.8 million, respectively. As of December 31, 2023, current and long-term product liability reserves were $11.4 million and $5.1 million, respectively. Current product liability reserves are included within other liabilities and long-term product liability reserves are included within other non-current liabilities in the Condensed Consolidated Balance Sheets. These amounts are not reduced for insurance recoveries for claims above the Company's self-insured retention level. As of March 31, 2024 and December 31, 2023, the Company had $0.5 million and $3.9 million, respectively, of estimated insurance recoveries included in other current assets in the Condensed Consolidated Balance Sheets.

Reserves for product-related lawsuits were estimated using a combination of actual case reserves and actuarial methods. Based on the Company’s experience in defending product liability claims, management believes the reserves are adequate for estimated case resolutions on aggregate self-insured claims and insured claims. Any recoveries from insurance carriers are dependent upon the legal sufficiency of claims and solvency of insurance carriers.

As of March 31, 2024 and December 31, 2023, the Company had reserves of $52.6 million and $56.8 million, respectively, for warranty and other related claims included in product warranties and other non-current liabilities in the Condensed Consolidated Balance Sheets. Certain of these warranty and other related claims involve matters in dispute that ultimately are resolved by negotiation, arbitration, or litigation. Refer to Note 18, “Guarantees,” for further information.

It is reasonably possible that the estimates for warranty and other related claims, product liability, asbestos-related claims, and other various legal matters may change based upon new information that may arise or matters that are beyond the scope of the Company’s historical experience. Presently, there are no reliable methods to estimate the amount of any such potential changes. The ultimate resolution of these matters, individually and in the aggregate, is not expected to have a material adverse effect on the Company’s financial condition, results of operations or cash flows.

 

In July 2017, the Company received an Information Request from the United States Environmental Protection Agency (“U.S. EPA”) relating to the sales of cranes manufactured between January 1, 2014 and July 31, 2017 and the Company’s related participation in the Transition Program for Equipment Manufacturers (the “TPEM” program). The TPEM program allowed equipment manufacturers to delay installing engines meeting Tier 4 final emission standards in their products, subject to certain percentage allowance restrictions. The Company has provided, and continues to provide, information to the U.S. EPA and the U.S. Department of Justice (“U.S. DOJ”) on the approximately 1,420 engines included in the Company’s cranes relating to the TPEM program and other certification matters. The Company is engaged in confidential discussions with the U.S. EPA and U.S. DOJ with respect to these matters.

 

Based on management's current assessment of the facts underlying these matters, the total recorded estimated liability in accounts payable and accrued expenses in the Company’s Condensed Consolidated Balance Sheets was $36.1 million as of March 31, 2024 and December 31, 2023. Other than the foregoing, the Company is unable to provide further meaningful quantification as to the final resolution of these matters. However, the Company calculated the statutory maximum penalties under the Clean Air Act to be approximately $174.0 million. The Company believes it has strong legal and factual defenses and will vigorously defend any allegations of noncompliance and the factors that could apply in the assessment of any civil penalty. Final resolution of these matters may have a material impact on the Company’s financial condition, results of operations or cash flows.

18. Guarantees

The Company periodically enters into transactions with customers that provide for buyback commitments. The Company evaluates each agreement at inception to determine if the customer has a significant economic incentive to exercise the buyback option. If it is determined that the customer has a significant economic incentive to exercise that right, the revenue is deferred and the agreement is accounted for as a lease in accordance with ASC Topic 842 – “Leases” (“Topic 842”). If it is determined that the customer does not have a significant economic incentive to exercise that right, then revenue is recognized when control

17


 

of the product is transferred to the customer. The revenue deferred related to buyback obligations accounted for under Topic 842 included in other current and non-current liabilities as of March 31, 2024 and December 31, 2023 was $30.4 million and $32.2 million, respectively. The total amount of buyback commitments given by the Company and outstanding as of March 31, 2024 and December 31, 2023 was $40.9 million and $43.4 million, respectively. These amounts are not reduced for amounts the Company would recover from the repossession and subsequent resale of the cranes. The buyback commitments expire at various times through 2032. The Company also has various loss guarantees with maximum liabilities of $13.5 million and $13.0 million as of March 31, 2024 and December 31, 2023, respectively. These amounts are not reduced for amounts the Company would recover from the repossession and subsequent resale of the cranes securing the related guarantees.

In the normal course of business, the Company provides its customers a warranty covering workmanship, and in some cases materials, on products manufactured by the Company. Such warranties generally provide that products will be free from defects for periods ranging from 12 months to 60 months. In addition, the Company may incur other warranty related costs outside of its standard warranty period. Costs for other warranty-related work are recorded in the period a loss is probable and can be reasonably estimated. Below is a table summarizing the warranty and other warranty related work for the three months ended March 31, 2024 and 2023.

 

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

Balance at beginning of period

 

$

56.8

 

 

$

58.0

 

Adjustments to accruals for warranties

 

 

5.3

 

 

 

6.6

 

Settlements made (in cash or in kind) during
   the period

 

 

(8.8

)

 

 

(8.5

)

Currency translation

 

 

(0.7

)

 

 

0.3

 

Balance at end of period

 

$

52.6

 

 

$

56.4

 

The long-term portion of the warranty liability is recorded in other non-current liabilities in the Condensed Consolidated Balance Sheets.

The revenue deferred related to extended warranty periods included in other current and non-current liabilities as of March 31, 2024 and December 31, 2023 was $7.3 million and $6.1 million, respectively.

19. Employee Benefit Plans

The Company provides certain pension, health care, and death benefits to eligible retirees and their dependents. The funding mechanism for such benefits varies based on the country where the plan is located and the related plan. Eligibility for pension coverage is based on retirement qualifications. Healthcare benefits may be subject to deductibles, co-payments, and other limitations. The Company reserves the right to modify benefits unless prohibited by local laws or regulations.

The components of net periodic benefit cost for the three months ended March 31, 2024 and 2023 are summarized as follows:

 

 

Three Months Ended March 31, 2024

 

 

 

 

 

 

 

 

 

Postretirement

 

 

 

U.S.

 

 

Non-U.S.

 

 

Health and

 

 

 

Pension

 

 

Pension

 

 

Other

 

 

 

Plan

 

 

Plans

 

 

Plans

 

Service cost - benefits earned during the period

 

$

 

 

$

0.3

 

 

$

 

Interest cost of projected benefit obligations

 

 

1.3

 

 

 

0.7

 

 

 

0.1

 

Expected return on plan assets

 

 

(1.0

)

 

 

(0.4

)

 

 

 

Amortization of prior service cost

 

 

 

 

 

 

 

 

 

Amortization of actuarial net (gain) loss

 

 

0.5

 

 

 

 

 

 

(0.4

)

Net periodic benefit cost

 

$

0.8

 

 

$

0.6

 

 

$

(0.3

)

 

18


 

 

 

Three Months Ended March 31, 2023

 

 

 

 

 

 

 

 

 

Postretirement

 

 

 

U.S.

 

 

Non-U.S.

 

 

Health and

 

 

 

Pension

 

 

Pension

 

 

Other

 

 

 

Plan

 

 

Plans

 

 

Plans

 

Service cost - benefits earned during the period

 

$

 

 

$

0.3

 

 

$

 

Interest cost of projected benefit obligations

 

 

1.4

 

 

 

0.7

 

 

 

0.1

 

Expected return on plan assets

 

 

(1.0

)

 

 

(0.4

)

 

 

 

Amortization of prior service cost

 

 

 

 

 

 

 

 

(0.3

)

Amortization of actuarial net loss

 

 

0.6

 

 

 

0.4

 

 

 

 

Net periodic benefit cost

 

$

1.0

 

 

$

1.0

 

 

$

(0.2

)

The components of net periodic benefit cost other than the service cost component are included in other income (expense) - net in the Condensed Consolidated Statements of Operations.

19


 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, including the financial statements, accompanying notes and Management’s Discussion and Analysis of Financial Condition and Results of Operations therein, and the interim condensed consolidated financial statements and accompanying notes included in this Quarterly Report on Form 10-Q.

All dollar amounts are in millions throughout the tables included in Management’s Discussion and Analysis of Financial Conditions and Results of Operations unless otherwise indicated.

Cautionary Statements Regarding Forward-Looking Information

All of the statements in this Quarterly Report on Form 10-Q, other than historical facts, are forward-looking statements, including, without limitation, the statements made in the “Management's Discussion and Analysis of Financial Condition and Results of Operations.” As a general matter, forward-looking statements are those focused upon anticipated events or trends, expectations and beliefs relating to matters that are not historical in nature. The words “could,” “should,” “may,” “feel,” “anticipate,” “aim,” “preliminary,” “expect,” “believe,” “estimate,” “intend,” “intent,” “plan,” “will,” “foresee,” “project,” “forecast,” or the negative thereof or variations thereon, and similar expressions identify forward-looking statements.

The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for these forward-looking statements. In order to comply with the terms of the safe harbor, the Company notes that forward-looking statements are subject to known and unknown risks, uncertainties and other factors relating to the Company’s operations and business environment, all of which are difficult to predict and many of which are beyond the control of the Company. These known and unknown risks, uncertainties and other factors could cause actual results to differ materially from those matters expressed in, anticipated by or implied by such forward-looking statements. These risks, uncertainties, and other factors include, but are not limited to:

Macroeconomic conditions, including inflation, high interest rates and recessionary concerns, as well as continuing global supply chain constraints, labor constraints, logistics constraints and cost pressures such as changes in raw material and commodity costs, have had, and may continue to have, a negative impact on Manitowoc’s ability to convert backlog into revenue which could, and has, impacted its financial condition, cash flows, and results of operations (including future uncertain impacts);
actions of competitors;
changes in economic or industry conditions generally or in the markets served by Manitowoc;
geopolitical events, including the ongoing conflicts in Ukraine and in the Middle East, other political and economic conditions and risks and other geographic factors, has had and may continue to lead to market disruptions, including volatility in commodity prices (including oil and gas), raw material and component costs, energy prices, inflation, consumer behavior, supply chain, and credit and capital markets, and could result in the impairment of assets;
changes in customer demand, including changes in global demand for high-capacity lifting equipment, changes in demand for lifting equipment in emerging economies and changes in demand for used lifting equipment including changes in government approval and funding of projects;
the ability to convert backlog, orders and order activity into sales and the timing of those sales;
failure to comply with regulatory requirements related to the products and aftermarket services the Company sells;
the ability to capitalize on key strategic opportunities and the ability to implement Manitowoc’s long-term initiatives;
impairment of goodwill and/or intangible assets;
changes in revenues, margins and costs;
the ability to increase operational efficiencies across Manitowoc and to capitalize on those efficiencies;
the ability to generate cash and manage working capital consistent with Manitowoc’s stated goals;
work stoppages, labor negotiations, labor rates and labor costs;
the Company’s ability to attract and retain qualified personnel;
changes in the capital and financial markets;

20


 

the ability to complete and appropriately integrate acquisitions, strategic alliances, joint ventures or other significant transactions;
issues associated with the availability and viability of suppliers;
the ability to significantly improve profitability;
realization of anticipated earnings enhancements, cost savings, strategic options and other synergies, and the anticipated timing to realize those savings, synergies and options;
the ability to focus on customers, new technologies and innovation;
uncertainties associated with new product introductions, the successful development and market acceptance of new and innovative products that drive growth;
the replacement cycle of technologically obsolete products;
risks associated with high debt leverage;
foreign currency fluctuation and its impact on reported results;
the ability of Manitowoc's customers to receive financing;
risks associated with data security and technological systems and protections;
the ability to direct resources to those areas that will deliver the highest returns;
risks associated with manufacturing or design defects;
natural disasters, other weather events, pandemics and other public health crises disrupting commerce in one or more regions of the world;
issues relating to the ability to timely and effectively execute on manufacturing strategies, general efficiencies and capacity utilization of the Company’s facilities;
the ability to focus and capitalize on product and service quality and reliability;
issues associated with the quality of materials, components and products sourced from third parties and the ability to successfully resolve those issues;
issues related to workforce reductions and potential subsequent rehiring;
changes in laws throughout the world, including governmental regulations on climate change;
the inability to defend against potential infringement claims on intellectual property rights;
the ability to sell products and services through distributors and other third parties;
issues affecting the effective tax rate for the year;
acts of terrorism; and
other risk factors detailed in Manitowoc's 2023 Annual Report on Form 10-K, as such may be amended or supplemented in Manitowoc’s subsequently filed Quarterly Reports on 10-Q (including this report), and its other filings with the United States Securities and Exchange Commission.

These statements reflect the current views and assumptions of management with respect to future events. Except to the extent required by the federal securities laws, the Company does not undertake, and hereby disclaims, any duty to update these forward-looking statements, even though its situation and circumstances may change in the future. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this report. The inclusion of any statement in this report does not constitute an admission by the Company or any other person that the events or circumstances described in such statement are material.

Current Events

Supply Chain and Logistics Constraints

The Company continues to actively monitor global supply chain and logistics constraints which had a negative impact on the Company’s ability to timely source parts, complete and ship units, and service cranes for the three months ended March 31, 2024. While the Company has experienced some relief of the supply chain and logistics constraints, supply chains for certain key components remain distressed. The Company continues to actively monitor and manage supply chain constraints through alternative sourcing of parts and adapting production to limit waste and inefficiencies in the facilities. Continuing or worsening

21


 

supply chain and logistics constraints may have a material adverse impact on the Company’s financial condition, results of operations, or cash flows.

Results of Operations for the three months ended March 31, 2024 and 2023:

 

 

Three Months Ended
March 31,

 

 

 

 

 

 

2024

 

 

2023

 

 

Percentage Change

 

Orders

 

$

554.1

 

 

$

524.8

 

 

 

5.6

%

Backlog

 

 

971.3

 

 

 

1,075.7

 

 

 

(9.7

)%

Net sales

 

 

495.1

 

 

 

508.3

 

 

 

(2.6

)%

Gross profit

 

 

92.5

 

 

 

106.3

 

 

 

(13.0

)%

Gross profit %

 

 

18.7

%

 

 

20.9

%

 

 

 

Engineering, selling, and administrative
  expenses

 

 

76.0

 

 

75.1

 

 

 

1.2

%

Interest expense

 

 

9.2

 

 

 

8.1

 

 

 

13.6

%

Provision for income taxes

 

 

1.9

 

 

 

4.2

 

 

 

(54.8

)%

*Measure not meaningful

Orders and Backlog

Backlog represents the dollar value of orders which are expected to be recognized in net sales in the future. Orders are included in backlog when an executed binding contract with a price that has a floor has been received but has not been recognized in net sales. Orders and backlog are not measures defined by accounting principles generally accepted in the United States of America (“GAAP”) and our methodology for determining orders and backlog may vary from the methodology used by other companies. Management uses orders and backlog for capacity and resource planning. We believe this information is useful to investors to provide an indication of our future revenues.

Orders for the three months ended March 31, 2024 increased 5.6% to $554.1 million from $524.8 million for the same period in 2023. The increase was primarily attributable to higher demand in the EURAF segment, mainly in the Company’s mobile product offering. Orders were favorably impacted by $2.0 million from changes in foreign currency exchange rates.

As of March 31, 2024, total backlog was $971.3 million, a 5.9% increase from the December 31, 2023 backlog of $917.2 million, and a 9.7% decrease from the March 31, 2023 backlog of $1,075.7 million. The decrease in backlog from March 31, 2023 is primarily attributable to higher shipments due to continuing easing of supply chain and logistics constraints. Backlog was unfavorably impacted by $7.6 million and $1.7 million from December 31, 2023 and March 31, 2023, respectively, from changes in foreign currency exchange rates.

Net Sales

Consolidated net sales for the three months ended March 31, 2024 decreased 2.6% to $495.1 million from $508.3 million for the same period in 2023. This decrease was primarily attributable to lower new and non-new machine sales in the EURAF segment, partially offset by higher new and non-new machine sales in the Americas and MEAP segments. Net sales were favorably impacted by $2.3 million from changes in foreign currency exchange rates.

Gross Profit

Gross profit for the three months ended March 31, 2024 was $92.5 million, a decrease of $13.8 million compared to $106.3 million for the same period in 2023. The decrease was primarily attributable to lower net sales, unfavorable product mix, and lower absorbed costs due to lower manufacturing volume in EURAF. Gross profit was favorably impacted by $0.3 million from changes in foreign currency exchange rates.

Engineering, Selling, and Administrative Expenses

22


 

Engineering, selling, and administrative expenses were $76.0 million for the three months ended March 31, 2024 compared to $75.1 million for the same period in 2023. Engineering, selling and administrative expenses were unfavorably impacted by $0.4 million from changes in foreign currency exchange rates.

Interest Expense

Interest expense for the three months ended March 31, 2024 totaled $9.2 million compared to $8.1 million for the same period in 2023. Interest expense increased year-over-year primarily due to higher debt and interest rates on borrowings from the Company’s ABL revolving credit facility.

Provision for Income Taxes

For the three months ended March 31, 2024 and 2023, the Company recorded a provision for income taxes of $1.9 million and $4.2 million, respectively. The decrease in the Company’s provision for income taxes for the three months ended March 31, 2024 compared to the prior year is due to lower year-to-date income partially offset by a change in jurisdictional mix. In addition, the Company’s effective tax rate varies from the U.S. federal statutory rate of 21% due to results of foreign operations that are subject to income taxes at different statutory rates and losses in both the U.S. and foreign jurisdictions where no tax benefit can be realized.

Segment Operating Performance

The Company manages its business primarily on a geographic basis. The Company has three reportable segments: the Americas segment, EURAF segment, and MEAP segment. Further information regarding the Company’s reportable segments can be found in Note 16, “Segments,” to the Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q.

 

 

Three Months Ended
March 31,

 

 

 

 

 

 

 

 

 

2024

 

 

2023

 

 

Dollar Change

 

 

Percentage Change

 

Net Sales

 

 

 

 

 

 

 

 

 

 

 

 

Americas

 

$

283.2

 

 

$

264.4

 

 

$

18.8

 

 

 

7.1

%

EURAF

 

 

143.0

 

 

 

178.2

 

 

 

(35.2

)

 

 

(19.8

)%

MEAP

 

 

68.9

 

 

 

65.7

 

 

 

3.2

 

 

 

4.9

%

 

 

 

 

 

 

 

 

 

 

 

 

 

Segment Operating
   Income (Loss)

 

 

 

 

 

 

 

 

 

 

 

 

Americas

 

$

29.5

 

 

$

28.5

 

 

$

1.0

 

 

 

3.5

%

EURAF

 

 

(11.8

)

 

 

3.6

 

 

 

(15.4

)

 

*

 

MEAP

 

 

8.2

 

 

 

8.6

 

 

 

(0.4

)

 

 

(4.7

)%

*Measure not meaningful

Americas

Americas segment net sales increased 7.1% for the three months ended March 31, 2024 to $283.2 million from $264.4 million for the same period in 2023. The increase was primarily attributable to higher new machine sales, favorable product mix and pricing actions. Non-new machine sales were relatively flat year-over-year.

Americas segment operating income increased 3.5% for the three months ended March 31, 2024 to $29.5 million from $28.5 million for the three months ended March 31, 2023. The increase was primarily due to higher net sales.

EURAF

EURAF segment net sales decreased 19.8% for the three months ended March 31, 2024 to $143.0 million from $178.2 million for the same period in 2023. The decrease was primarily due to lower new machine sales in the Company's tower product offering and lower non-new machine sales. Segment net sales was favorably impacted by $2.2 million from changes in foreign currency exchange rates.

EURAF segment operating loss was $11.8 million for the three months ended March 31, 2024 compared to operating income of $3.6 million for the same period in 2023. The change was primarily due to lower net sales, unfavorable product mix, and higher

23


 

labor costs in engineering, selling and administrative expenses. Segment operating income was unfavorably impacted by $0.1 million from changes in foreign currency exchange rates.

MEAP

MEAP segment net sales increased 4.9% for the three months ended March 31, 2024 to $68.9 million from $65.7 million for the same period in 2023. The increase was primarily attributable to higher non-new machine sales. MEAP segment net sales was unfavorably impacted by $0.2 million from changes in foreign currency exchange rates.

MEAP segment operating income decreased 4.7% for the three months ended March 31, 2024 to $8.2 million from $8.6 million for the same period in 2023. The decrease was primarily due to unfavorable product mix. Segment operating income was favorably impacted by $0.1 million from changes in foreign currency exchange rates.

Financial Condition

Cash Flows

A summary of cash flows for the three months ended March 31, 2024 and 2023 are as follows:

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

Net cash provided by (used for) operating activities

 

$

(30.6

)

 

$

15.4

 

Net cash used for investing activities

 

 

(12.0

)

 

 

(8.6

)

Net cash provided by (used for) financing activities

 

 

40.2

 

 

 

(15.1

)

Cash and cash equivalents

 

 

31.5

 

 

 

56.5

 

Cash Flows From Operating Activities

Net cash used for operating activities of $30.6 million for the three months ended March 31, 2024 increased $46.0 million from net cash provided by operating activities of $15.4 million for the same period in 2023. The increase in net cash used for operating activities was primarily due to lower net income adjusted for non-cash items, and higher use of cash driven by an increase in accounts receivable, and a decrease in accrued expenses and other liabilities. This was partially offset by a decrease in cash used for inventories.

Cash Flows From Investing Activities

Net cash used for investing activities of $12.0 million for the three months ended March 31, 2024 increased $3.4 million from net cash used for investing activities of $8.6 million for the same period in 2023. The increase in net cash used for investing activities is due to $1.6 million of additional capital expenditures and a $1.8 million reduction in proceeds from sale of property, plant, and equipment.

Cash Flows From Financing Activities

Net cash provided by financing activities of $40.2 million for the three months ended March 31, 2024 increased $55.3 million from net cash used for financing activities of $15.1 million for the same period in 2023. The increase is primarily driven by proceeds of $29.7 million and $14.0 million on the Company’s overdraft facilities and ABL revolving credit facility, respectively, as compared to payments of $11.9 million in the prior year.

Liquidity and Capital Resources

The Company’s liquidity position as of March 31, 2024 and December 31, 2023 is summarized as follows:

 

 

March 31, 2024

 

 

December 31, 2023

 

Cash and cash equivalents

 

$

31.5

 

 

$

34.4

 

Revolver borrowing capacity

 

 

275.0

 

 

 

275.0

 

Other debt availability

 

 

44.1

 

 

 

45.2

 

Less: Borrowings on revolver

 

 

(74.0

)

 

 

(60.0

)

Less: Borrowings on other debt

 

 

(40.5

)

 

 

(11.2

)

Less: Outstanding letters of credit

 

 

(3.4

)

 

 

(3.4

)

Total liquidity

 

$

232.7

 

 

$

280.0

 

 

24


 

The Company believes its liquidity and expected cash flows from operations are sufficient to meet expected working capital, capital expenditure, and other general ongoing operational needs in the subsequent twelve months.

Cash Sources

The Company has historically relied primarily on cash flows from operations, borrowings under revolving credit facilities, issuances of notes and other forms of debt financing as its sources of cash.

The maximum availability under the Company’s current ABL Revolving Credit Facility is $275.0 million. The borrowing capacity under the ABL Revolving Credit Facility is based on the value of inventory, accounts receivable and certain fixed assets of the Loan Parties. The Loan Parties’ obligations under the ABL Revolving Credit Facility are secured on a first-priority basis, subject to certain exceptions and permitted liens, by substantially all of the personal property and fee-owned real property of the Loan Parties. The liens securing the ABL Revolving Credit Facility are senior in priority to the second-priority liens securing the obligations under the senior secured second lien notes due on April 1, 2026 (the "2026 Notes") and the related guarantees. The ABL Revolving Credit Facility has a maturity date of May 19, 2027 (with a springing maturity date of December 30, 2025 if the 2026 Notes have not been repaid in full or refinanced prior to December 30, 2025), and includes a $75.0 million letter of credit sub-facility, $10.0 million of which is available to the Company’s German subsidiary that is a borrower under the ABL Revolving Credit Facility.

In addition to the ABL Revolving Credit Facility, the Company has access to non-committed overdraft facilities to fund working capital in Europe and China. There are six facilities, of which five are denominated in Euros totaling €37.0 million and one denominated in Chinese Yuan totaling ¥30.0 million. Total U.S. dollar availability as of March 31, 2024 for the six overdraft facilities is $44.1 million, with $40.5 million outstanding.

Debt

Outstanding debt as of March 31, 2024 and December 31, 2023 is summarized as follows:

 

 

March 31, 2024

 

 

December 31, 2023

 

Borrowing under senior secured asset based
   revolving credit facility

 

$

74.0

 

 

$

60.0

 

Senior secured second lien notes due 2026

 

 

300.0

 

 

 

300.0

 

Other debt

 

 

42.7

 

 

 

13.7

 

Deferred financing costs

 

 

(1.5

)

 

 

(1.6

)

Total debt

 

 

415.2

 

 

 

372.1

 

Short-term borrowings and current portion of long-term
   debt

 

 

(42.5

)

 

 

(13.4

)

Long-term debt

 

$

372.7

 

 

$

358.7

 

Both the ABL Revolving Credit Facility and 2026 Notes include customary covenants and events of default. Refer to Note 10, “Debt,” to the Condensed Consolidated Financial Statements for additional discussions of the covenants for the ABL Revolving Credit Facility and the 2026 Notes. Based upon management’s current plans and outlook, the Company believes it will be able to comply with these covenants during the subsequent twelve months. From time to time, the Company seeks to opportunistically raise capital in the debt capital markets and bank credit markets.

Non-GAAP Measures

The Company uses EBITDA, adjusted EBITDA, adjusted operating income, Adjusted ROIC and free cash flows, which are financial measures that are not prepared in accordance with GAAP, as additional metrics to evaluate the Company’s performance. The Company believes these non-GAAP measures provide important supplemental information to readers regarding business trends that can be used in evaluating its results because these financial measures provide a consistent method of comparing financial performance and are commonly used by investors to assess performance. These non-GAAP financial measures should be considered together with, and are not substitutes for, the GAAP financial information provided herein.

Adjusted ROIC

Adjusted ROIC measures how efficiently the Company uses invested capital in its operations. Adjusted ROIC is not a measure defined by GAAP and the Company’s methodology for determining Adjusted ROIC may vary from the methodology used by

25


 

other companies. Management and the Board of Directors use Adjusted ROIC as a measure to assess operational performance and capital allocation. The Company believes this information is useful to investors as it provides a measure of value creation as a percentage of capital invested.

Adjusted ROIC is determined by dividing adjusted net operating profit after tax (“Adjusted NOPAT”) for the trailing twelve-months ended by the five-quarter average of invested capital. Adjusted NOPAT is calculated for each quarter by taking operating income plus the addback of amortization of intangible assets and the addback or subtraction of restructuring expenses, certain other non-recurring items - net and provision for income taxes, which is determined using a 15% tax rate. Invested capital is defined as net total assets less cash and cash equivalents and income tax assets/liabilities - net plus short-term and long-term debt. Income taxes are defined as income tax payables/receivables, net deferred tax assets/liabilities, and uncertain tax positions.

 

The Company’s Adjusted ROIC as of March 31, 2024 was 9.5%. Below is the calculation of Adjusted ROIC as of March 31, 2024.

 

 

Three Months Ended

 

 

 

 

 

 

March 31, 2024

 

 

December 31, 2023

 

 

September 30, 2023

 

 

June 30, 2023

 

 

Trailing Twelve Months

 

Operating income

 

$

15.2

 

 

$

9.8

 

 

$

18.0

 

 

$

34.4

 

 

$

77.4

 

Amortization of intangible assets

 

 

0.7

 

 

 

0.8

 

 

 

0.7

 

 

 

0.7

 

 

 

2.9

 

Restructuring expense

 

 

0.6

 

 

 

0.3

 

 

 

0.7

 

 

 

0.3

 

 

 

1.9

 

Other non-recurring items - net1

 

 

0.1

 

 

 

10.8

 

 

 

0.2

 

 

 

10.8

 

 

 

21.9

 

Adjusted operating income

 

 

16.6

 

 

 

21.7

 

 

 

19.6

 

 

 

46.2

 

 

 

104.1

 

Provision for income taxes

 

 

(2.5

)

 

 

(3.3

)

 

 

(2.9

)

 

 

(6.9

)

 

 

(15.6

)

Adjusted NOPAT

 

$

14.1

 

 

$

18.4

 

 

$

16.7

 

 

$

39.3

 

 

$

88.5

 

 

 

 

March 31, 2024

 

 

December 31, 2023

 

 

September 30, 2023

 

 

June 30, 2023

 

 

March 31, 2023

 

 

5-Quarter Average

 

Total assets

 

$

1,780.6

 

 

$

1,706.7

 

 

$

1,692.2

 

 

$

1,701.1

 

 

$

1,691.1

 

 

 

1,714.3

 

Total liabilities

 

 

(1,184.6

)

 

 

(1,103.4

)

 

 

(1,119.2

)

 

 

(1,121.7

)

 

 

(1,138.3

)

 

 

(1,133.4

)

Net total assets

 

 

596.0

 

 

 

603.3

 

 

 

573.0

 

 

 

579.4

 

 

 

552.8

 

 

 

580.9

 

Cash and cash equivalents

 

 

(31.5

)

 

 

(34.4

)

 

 

(40.0

)

 

 

(25.9

)

 

 

(56.5

)

 

 

(37.7

)

Short-term borrowings and current portion of long-term debt

 

 

42.5

 

 

 

13.4

 

 

 

30.3

 

 

 

6.7

 

 

 

7.9

 

 

 

20.2

 

Long-term debt

 

 

372.7

 

 

 

358.7

 

 

 

368.5

 

 

 

380.7

 

 

 

369.5

 

 

 

370.0

 

Income tax (assets) liabilities - net

 

 

(3.4

)

 

 

(2.6

)

 

 

(4.3

)

 

 

(2.1

)

 

 

6.3

 

 

 

(1.2

)

Invested capital

 

$

976.3

 

 

$

938.4

 

 

$

927.5

 

 

$

938.8

 

 

$

880.0

 

 

$

932.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted ROIC

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

9.5

%

(1) Other non-recurring items - net for the three months ended March 31, 2024 relate to $0.1 million of one-time costs. Other non-recurring items – net for the trailing twelve months relate to $21.2 million of costs associated with a legal matter with the U.S. EPA and $0.7 million of one-time costs. Refer to the Company’s previously filed Form 10-K and Form 10-Qs for a description of other non-recurring items - net for the three months ended December 31, 2023, September 30, 2023, and June 30, 2023.

 

EBITDA and Adjusted EBITDA

26


 

The Company defines EBITDA as net income before interest, taxes, depreciation, and amortization. The Company defines adjusted EBITDA as EBITDA plus the addback or subtraction of restructuring expense, other income (expense) - net, and certain other non-recurring items.

The reconciliation of net income to EBITDA, and further to adjusted EBITDA for the three months ended March 31, 2024 and 2023, are summarized as follows:

 

Three Months Ended
March 31,

 

 

Trailing Twelve

 

 

2024

 

 

2023

 

 

Months

 

Net income

$

4.5

 

 

$

16.5

 

 

$

27.2

 

Interest expense and amortization of deferred
   financing fees

 

9.5

 

 

 

8.4

 

 

 

36.3

 

Provision for income taxes

 

1.9

 

 

 

4.2

 

 

 

2.7

 

Depreciation expense

 

14.7

 

 

 

13.9

 

 

 

57.4

 

Amortization of intangible assets

 

0.7

 

 

 

1.0

 

 

 

2.9

 

EBITDA

 

31.3

 

 

 

44.0

 

 

 

126.5

 

Restructuring expense

 

0.6

 

 

 

 

 

 

1.9

 

Other non-recurring items - net (1)

 

0.1

 

 

 

 

 

 

21.9

 

Other (income) expense - net (2)

 

(0.7

)

 

 

1.1

 

 

 

11.2

 

Adjusted EBITDA

$

31.3

 

 

$

45.1

 

 

$

161.5

 

 

 

 

 

 

 

 

 

Adjusted EBITDA margin percentage

 

6.3

%

 

 

8.9

%

 

 

7.3

%

 

(1)
Other non-recurring items - net for the three months ended March 31, 2024 relate to $0.1 million of one-time costs. Other non-recurring items - net for the trailing twelve months relate to $21.2 million of costs associated with a legal matter with the U.S. EPA and $0.7 million of one-time costs.
(2)
Other (income) expense - net includes net foreign currency gains (losses), other components of net periodic pension costs, and other items in the three and trailing twelve months ended March 31, 2024 and the three months ended March 31, 2023. Other (income) expense – net for the trailing twelve months includes a $9.3 million write-off of non-cash foreign currency translation adjustments from the curtailment of operations in Russia.

Free Cash Flows

Free cash flows is defined as net cash provided by (used for) operating activities less cash outflow from investment in capital expenditures. The reconciliation of net cash provided by (used for) operating activities to free cash flows for the three months ended March 31, 2024 and 2023 are summarized as follows:

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

Net cash provided by (used for) operating activities

 

$

(30.6

)

 

$

15.4

 

Capital expenditures

 

 

(12.2

)

 

 

(10.6

)

Free cash flows

 

$

(42.8

)

 

$

4.8

 

Critical Accounting Policies

The Company’s critical accounting policies have not materially changed since the 2023 Annual Report on Form 10-K was filed. Refer to the Critical Accounting Policies in “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in the Annual Report on Form 10-K for the year ended December 31, 2023 for information about the Company’s policies, methodology and assumptions related to critical accounting policies.

Item 3. Quantitative and Qualitative Disclosure about Market Risk

The Company’s market risk disclosures have not materially changed since the 2023 Annual Report on Form 10-K was filed. The Company’s quantitative and qualitative disclosures about market risk are incorporated by reference from Part II, Item 7A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.

27


 

Item 4. Controls and Procedures

Disclosure Controls and Procedures: The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, have evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (“Exchange Act”)) as of the end of the period covered by this report. Based on such evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, the Company’s disclosure controls and procedures are effective in recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act, and that such information is accumulated and communicated to the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely discussions regarding required disclosure.

Changes in Internal Control Over Financial Reporting: The Company's management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). During the period covered by this report, the Company made no changes that have materially affected, or that are reasonably likely to materially affect, its internal control over financial reporting.

28


 

PART II. OTHER INFORMATION

Item 1A. Risk Factors

There have been no material changes to the risk factors previously disclosed in Part I, Item 1A, “Risk Factors,” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, which was filed with the Securities and Exchange Commission on February 23, 2024.

Item 5. Other Information

(c) During the three months ended March 31, 2024, no director or Section 16 officer of the Company adopted a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement", as each term is defined in Item 408 of Regulation S-K.

Item 6. Exhibits

 

Exhibit No.

 

Description

 

Filed/Furnished

Herewith

 

 

 

 

 

 

 

31

 

Rule 13a - 14(a)/15d - 14(a) Certifications

 

X

(1)

 

 

 

 

 

 

32.1

 

Certification of CEO pursuant to 18 U.S.C. Section 1350

 

X

(2)

 

 

 

 

 

 

32.2

 

Certification of CFO pursuant to 18 U.S.C. Section 1350

 

X

(2)

 

 

 

 

 

 

101.INS

 

Inline XBRL Instance Document – The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

 

X

(1)

 

 

 

 

 

 

101.SCH

 

Inline XBRL Taxonomy Extension Schema Document

 

X

(1)

 

 

 

 

 

 

101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document

 

X

(1)

 

 

 

 

 

 

101.DEF

 

Inline XBRL Taxonomy Extension Definition Linkbase Document

 

X

(1)

 

 

 

 

 

 

101.LAB

 

Inline XBRL Taxonomy Extension Labels Linkbase Document

 

X

(1)

 

 

 

 

 

 

101.PRE

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document

 

X

(1)

 

 

 

 

 

 

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

X

(1)

 

 

 

 

 

 

 

(1) Filed Herewith

(2) Furnished Herewith

29


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: May 8, 2024

The Manitowoc Company, Inc.

 

(Registrant)

 

 

 

 

 

/s/ Aaron H. Ravenscroft

 

Aaron H. Ravenscroft

 

President and Chief Executive Officer

 

(Principal Executive Officer and Director)

 

 

 

/s/ Brian P. Regan

 

Brian P. Regan

 

Executive Vice President and Chief Financial Officer

 

(Principal Financial Officer)

 

 

 

/s/ Ryan M. Palmer

 

Ryan M. Palmer

 

Vice President, Corporate Controller and Principal Accounting Officer

 

(Principal Accounting Officer)

 

30


 

Exhibit 31

Certification of Principle Executive Officer

I, Aaron H. Ravenscroft, certify that:

1.
I have reviewed this Quarterly Report on Form 10-Q of The Manitowoc Company, Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 8, 2024

 

/s/ Aaron H. Ravenscroft

Aaron H. Ravenscroft

President and Chief Executive Officer

 

 


 

Certification of Principle Financial Officer

I, Brian P. Regan, certify that:

1.
I have reviewed this Quarterly Report on Form 10-Q of The Manitowoc Company, Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 8, 2024

 

/s/ Brian P. Regan

Brian P. Regan

Executive Vice President and Chief Financial Officer

 

 


 

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of The Manitowoc Company, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Aaron H. Ravenscroft, President and Chief Executive Officer of the Company, certify, pursuant to 18. U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the company as of the date and for the periods expressed in the Report.

 

/s/ Aaron H. Ravenscroft

Aaron H. Ravenscroft

President and Chief Executive Officer

May 8, 2024

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to The Manitowoc Company, Inc. and will be retained by The Manitowoc Company, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 


 

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of The Manitowoc Company, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Brian P. Regan, Executive Vice President and Chief Financial Officer of the Company, certify, pursuant to 18. U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the company as of the date and for the periods expressed in the Report.

 

/s/ Brian P. Regan

Brian P. Regan

Executive Vice President and Chief Financial Officer

May 8, 2024

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to The Manitowoc Company, Inc. and will be retained by The Manitowoc Company, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 


v3.24.1.u1
Document and Entity Information
3 Months Ended
Mar. 31, 2024
shares
Cover [Abstract]  
Entity Registrant Name The Manitowoc Company, Inc.
Entity Central Index Key 0000061986
Trading Symbol MTW
Document Type 10-Q
Document Period End Date Mar. 31, 2024
Document Fiscal Year Focus 2024
Amendment Flag false
Current Fiscal Year End Date --12-31
Entity Current Reporting Status Yes
Entity Filer Category Accelerated Filer
Entity Small Business false
Entity Emerging Growth Company false
Entity Shell Company false
Entity Shares Outstanding 35,540,950
Document Fiscal Period Focus Q1
Entity File Number 1-11978
Entity Tax Identification Number 39-0448110
Entity Address, Address Line One 11270 West Park Place
Entity Address, Address Line Two Suite 1000
Entity Address, City or Town Milwaukee
Entity Address, State or Province WI
Entity Address, Postal Zip Code 53224
City Area Code 414
Local Phone Number 760-4600
Entity Incorporation, State or Country Code WI
Title of 12(b) Security Common Stock, $.01 Par Value
Security Exchange Name NYSE
Entity Interactive Data Current Yes
Document Quarterly Report true
Document Transition Report false
v3.24.1.u1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Net sales $ 495.1 $ 508.3
Cost of sales 402.6 402.0
Gross profit 92.5 106.3
Operating costs and expenses:    
Engineering, selling and administrative expenses 76.0 75.1
Amortization of intangible assets 0.7 1.0
Restructuring expense 0.6 0.0
Total operating costs and expenses 77.3 76.1
Operating income 15.2 30.2
Other income (expense):    
Interest expense (9.2) (8.1)
Amortization of deferred financing fees (0.3) (0.3)
Other income (expense) - net 0.7 (1.1)
Total other expense (8.8) (9.5)
Income before income taxes 6.4 20.7
Provision for income taxes 1.9 4.2
Net income $ 4.5 $ 16.5
Per Share Data    
Basic net income per common share $ 0.13 $ 0.47
Diluted net income per common share $ 0.12 $ 0.46
Weighted average shares outstanding - basic 35,265,449 35,121,473
Weighted average shares outstanding - diluted 36,060,640 35,748,021
v3.24.1.u1
Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Statement of Comprehensive Income [Abstract]    
Net Income (Loss) $ 4.5 $ 16.5
Other comprehensive income (loss), net of income tax:    
Unrealized losses on derivatives, net of income tax provision of $0.0 and $0.0, respectively (1.6) (3.3)
Employee pension and postretirement benefit income (expense), net of income tax provision of $0.0 and $0.0, respectively 0.1 (1.0)
Foreign currency translation adjustments, net of income tax benefit of $0.6 and $0.2, respectively (11.0) 4.2
Total other comprehensive loss, net of income tax (12.5) (0.1)
Comprehensive income (loss) $ (8.0) $ 16.4
v3.24.1.u1
Condensed Consolidated Statements of Comprehensive Income (Loss) (Parenthetical) (Unaudited) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Statement of Comprehensive Income [Abstract]    
Unrealized loss on derivatives, net of income tax provision $ 0.0 $ 0.0
Employee pension and postretirement benefit income (expense), net of income tax provision 0.0 0.0
Foreign currency translation adjustments, net of income tax benefit $ 0.6 $ 0.2
v3.24.1.u1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Current Assets:    
Cash and cash equivalents $ 31.5 $ 34.4
Accounts receivable, less allowances of $5.9 and $6.1, respectively 290.3 278.8
Inventories - net 748.0 666.5
Notes receivable — net 5.7 6.7
Other current assets 43.9 46.6
Total current assets 1,119.4 1,033.0
Property, plant and equipment — net 357.5 366.1
Operating lease right-of-use assets 58.8 59.7
Goodwill 78.7 79.6
Intangible assets - net 123.3 125.6
Other non-current assets 42.9 42.7
Total assets 1,780.6 1,706.7
Current Liabilities:    
Accounts payable and accrued expenses 509.4 457.4
Customer advances 20.3 19.2
Short-term borrowings and current portion of long-term debt 42.5 13.4
Product warranties 41.3 47.1
Other liabilities 18.7 26.2
Total current liabilities 632.2 563.3
Non-Current Liabilities:    
Long-term debt 372.7 358.7
Operating lease liabilities 46.6 47.2
Deferred income taxes 7.4 7.5
Pension obligations 54.9 55.8
Postretirement health and other benefit obligations 5.4 5.6
Long-term deferred revenue 21.1 24.1
Other non-current liabilities 44.3 41.2
Total non-current liabilities 552.4 540.1
Commitments and contingencies (Note 17)
Stockholders' Equity:    
Preferred stock (3,500,000 shares authorized of $.01 par value; none outstanding) 0.0 0.0
Common stock (75,000,000 shares authorized, 40,793,983 shares issued, 35,540,950 and 35,094,993 shares outstanding, respectively) 0.4 0.4
Additional paid-in capital 608.5 613.1
Accumulated other comprehensive loss (98.9) (86.4)
Retained earnings 148.0 143.5
Treasury stock, at cost (5,253,033 and 5,698,990 shares, respectively) (62.0) (67.3)
Total stockholders' equity 596.0 603.3
Total liabilities and stockholders' equity $ 1,780.6 $ 1,706.7
v3.24.1.u1
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Accounts Receivable, allowances (in dollars) $ 5.9 $ 6.1
Preferred stock authorized (in shares) 3,500,000 3,500,000
Par value of preferred stock per share (in dollars per share) $ 0.01 $ 0.01
Preferred stock outstanding (in shares) 0 0
Common stock, shares authorized (in shares) 75,000,000 75,000,000
Common stock, shares issued (in shares) 40,793,983 40,793,983
Common stock, shares outstanding (in shares) 35,540,950 35,094,993
Treasury Stock, Common, Shares 5,253,033 5,698,990
v3.24.1.u1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash Flows from Operating Activities:    
Net income $ 4.5 $ 16.5
Adjustments to reconcile net income to cash provided by (used for) operating activities:    
Depreciation expense 14.7 13.9
Amortization of intangible assets 0.7 1.0
Stock-based compensation expense 3.7 3.1
Amortization of deferred financing fees 0.3 0.3
Loss on sale of property, plant, and equipment 0.2 0.0
Changes in operating assets and liabilities:    
Accounts receivable (15.3) 17.1
Inventories (89.1) (100.6)
Notes receivable 1.5 1.7
Other assets 1.1 1.6
Accounts payable 56.6 56.2
Accrued expenses and other liabilities (9.5) 4.6
Net cash provided by (used for) operating activities (30.6) 15.4
Cash Flows from Investing Activities:    
Capital expenditures (12.2) (10.6)
Proceeds from sale of fixed assets 0.2 2.0
Net cash used for investing activities (12.0) (8.6)
Cash Flows from Financing Activities:    
Proceeds from (payments on) revolving credit facility - net 14.0 (10.0)
Proceeds from (payments on) other debt - net 29.1 (1.9)
Exercises of stock options 0.0 0.3
Common stock repurchases 0.0 (3.5)
Other financing activities (2.9) 0.0
Net cash provided by (used for) financing activities 40.2 (15.1)
Effect of exchange rate changes on cash and cash equivalents (0.5) 0.4
Net decrease in cash and cash equivalents (2.9) (7.9)
Cash and cash equivalents at beginning of period 34.4 64.4
Cash and cash equivalents at end of period 31.5 56.5
Supplemental Cash Flow Information [Abstract]    
Interest paid 2.1 1.3
Income taxes paid $ 1.8 $ 1.7
v3.24.1.u1
Condensed Consolidated Statements of Equity - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Treasury Stock
Balance at beginning of period at Dec. 31, 2022   $ 0.4 $ 606.7 $ (107.9) $ 104.3 $ (65.7)
Increase (Decrease) in Stockholders' Equity            
Stock compensation plans     (4.0)     3.0
Stock-based compensation expense     3.1      
Other comprehensive loss       (0.1)    
Net Income (Loss) $ 16.5       16.5  
Common stock repurchases           (3.5)
Balance at end of period at Mar. 31, 2023 552.8 0.4 605.8 (108.0) 120.8 (66.2)
Balance at beginning of period at Dec. 31, 2023   0.4 613.1 (86.4) 143.5 (67.3)
Increase (Decrease) in Stockholders' Equity            
Stock compensation plans     (8.3)     5.3
Stock-based compensation expense     3.7      
Other comprehensive loss       (12.5)    
Net Income (Loss) 4.5       4.5  
Common stock repurchases           0.0
Balance at end of period at Mar. 31, 2024 $ 596.0 $ 0.4 $ 608.5 $ (98.9) $ 148.0 $ (62.0)
v3.24.1.u1
Pay vs Performance Disclosure - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Pay vs Performance Disclosure    
Net Income (Loss) $ 4.5 $ 16.5
v3.24.1.u1
Insider Trading Arrangements
3 Months Ended
Mar. 31, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
v3.24.1.u1
Company and Basis of Presentation
3 Months Ended
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Company and Basis of Presentation

1. Company and Basis of Presentation

The Manitowoc Company, Inc. (“Manitowoc” or the “Company”) was founded in 1902 and has over a 120-year tradition of providing high-quality, customer-focused products and support services to its markets. Headquartered in Milwaukee, Wisconsin, United States, Manitowoc is one of the world's leading providers of engineered lifting solutions. Manitowoc, through its wholly-owned subsidiaries, designs, manufactures, markets, distributes, and supports comprehensive product lines of mobile hydraulic cranes, lattice-boom crawler cranes, boom trucks, and tower cranes under the Aspen Equipment, Grove, Manitowoc, MGX Equipment Services, National Crane, Potain, and Shuttlelift brand names. The Company serves a wide variety of customers, including dealers, rental companies, contractors, and government entities, across the petrochemical, industrial, commercial construction, power and utilities, infrastructure and residential construction end markets. Due to the ongoing and predictable maintenance needed by cranes, as well as the high cost of crane downtime, Manitowoc’s aftermarket support operations provide the Company with a consistent stream of recurring revenue.

The Company has three reportable segments, the Americas segment, the Europe and Africa ("EURAF") segment and Middle East and Asia Pacific (“MEAP”) segment. The Americas segment includes the North America and South America continents. The EURAF reporting segment includes the Europe and Africa continents, excluding the Middle East region. The MEAP reporting segment includes the Asia and Australia continents and the Middle East region. The segments were identified using the “management approach,” which designates the internal organization that is used by management for making operating decisions and assessing performance. Refer to Note 16, “Segments,” for additional information.

In the opinion of management, the accompanying unaudited Condensed Consolidated Financial Statements contain all adjustments necessary for a fair statement of the results of operations for the three months ended March 31, 2024 and 2023, the cash flows for the same three-month periods, and the financial position as of March 31, 2024 and December 31, 2023, and except as otherwise discussed, such adjustments consist of only those of a normal recurring nature. The audited balance sheet as of December 31, 2023, was derived from the audited annual financial statements. The interim results are not necessarily indicative of results for a full year and do not contain information included in the Company’s annual consolidated financial statements and notes for the year ended December 31, 2023. Certain information and footnote disclosures, normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”), have been condensed or omitted pursuant to Securities and Exchange Commission rules and regulations dealing with interim financial statements. However, the Company believes that the disclosures made in the Condensed Consolidated Financial Statements included herein are adequate to make the information presented not misleading. It is suggested that these financial statements be read in conjunction with the financial statements and the notes thereto included in the Company’s latest annual report on Form 10-K.

All amounts, except per share data and share amounts, are in millions throughout the tables in these notes unless otherwise indicated.

v3.24.1.u1
Recent Accounting Changes and Pronouncements
3 Months Ended
Mar. 31, 2024
Accounting Standards Update and Change in Accounting Principle [Abstract]  
Recent Accounting Changes and Pronouncements

2. Recent Accounting Changes and Pronouncements

In November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2023-07, "Segment Reporting - Improvements to Reportable Segments Disclosures.” The amendments in this ASU improve reportable segment disclosure requirements, primarily through enhanced footnote disclosures about significant segment expenses. The standard is effective for annual periods beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company does not expect the adoption of this ASU will have a material impact on its consolidated financial statements.

In December 2023, the FASB issued ASU No. 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” The amendments in this ASU enhance the transparency and decision usefulness of income tax disclosures. The standard is effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The Company does not expect the adoption of this ASU will have a material impact on its consolidated financial statements.

v3.24.1.u1
Net Sales
3 Months Ended
Mar. 31, 2024
Revenue from Contract with Customer [Abstract]  
Net Sales

3. Net Sales

The Company defers revenue when cash payments are received in advance of satisfying the related performance obligation. These amounts are recorded as customer advances in the Condensed Consolidated Balance Sheets. The table below shows the change in the customer advances balance for the three months ended March 31, 2024 and 2023.

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

Balance at beginning of period

 

$

19.2

 

 

$

21.9

 

Cash received in advance of satisfying
   performance obligations

 

 

39.1

 

 

 

34.4

 

Revenue recognized

 

 

(37.7

)

 

 

(32.4

)

Currency translation

 

 

(0.3

)

 

 

0.1

 

Balance at end of period

 

$

20.3

 

 

$

24.0

 

Disaggregation of the Company’s revenue sources are disclosed in Note 16, “Segments.”

v3.24.1.u1
Fair Value of Financial Instruments
3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments

4. Fair Value of Financial Instruments

The following table sets forth the Company’s financial assets and liabilities related to foreign currency exchange contracts ("FX Forward Contracts") and The Manitowoc Company, Inc. Deferred Compensation Plan (the "Deferred Compensation Plan") that were accounted for at fair value as of March 31, 2024 and December 31, 2023.

 

 

Fair Value as of March 31, 2024

 

 

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 

Recognized Location

Current Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FX Forward Contracts

 

$

 

 

$

0.3

 

 

$

 

 

$

0.3

 

 

 Other current assets

Deferred Compensation Plan - Program B

 

 

8.9

 

 

 

 

 

 

 

 

 

8.9

 

 

 Other non-current assets

Total current assets at fair value

 

$

8.9

 

 

$

0.3

 

 

$

 

 

$

9.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FX Forward Contracts

 

$

 

 

$

1.1

 

 

$

 

 

$

1.1

 

 

 Accounts payable and
   accrued expenses

 

 

 

Fair Value as of December 31, 2023

 

 

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 

Recognized Location

Current Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FX Forward Contracts

 

$

 

 

$

1.6

 

 

$

 

 

$

1.6

 

 

 Other current assets

Deferred Compensation Plan - Program B

 

 

8.1

 

 

 

 

 

 

 

 

 

8.1

 

 

 Other non-current assets

Total current assets at fair value

 

$

8.1

 

 

$

1.6

 

 

$

 

 

$

9.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FX Forward Contracts

 

$

 

 

$

0.6

 

 

$

 

 

$

0.6

 

 

 Accounts payable and
   accrued expenses

The fair value of the $300.0 million senior secured second lien notes due on April 1, 2026, with an annual coupon rate of 9.000% (the “2026 Notes”), was approximately $300.2 million as of March 31, 2024 and $302.7 million as of December 31, 2023. Refer to Note 10, “Debt,” for a description of the 2026 Notes and the related carrying value.

The Company endeavors to utilize the best available information in measuring fair value. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company estimates the fair value of its 2026 Notes based on quoted market prices of the instruments; because these markets are typically actively traded, the liabilities are classified as Level 1 within the valuation hierarchy. The carrying values of cash and cash equivalents, accounts receivable, accounts payable and short-term variable debt, including any amounts outstanding under the

Company’s revolving credit facility, approximate fair value, without being discounted as of March 31, 2024, due to the short-term nature of these instruments.

FX Forward Contracts are valued through an independent valuation source which uses an industry standard data provider, with resulting valuations periodically validated through third-party or counterparty quotes. As such, these derivative instruments are classified within Level 2. Refer to Note 5, “Derivative Financial Instruments,” for additional information.

The Deferred Compensation Plan utilizes a rabbi trust to hold assets intended to satisfy the Company’s corresponding future benefit obligations. The plan assets and corresponding obligations for Program B under the Deferred Compensation Plan are classified within Level 1.

v3.24.1.u1
Derivative Financial Instruments
3 Months Ended
Mar. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments

5. Derivative Financial Instruments

The Company’s risk management objective is to ensure that business exposures to risks are minimized using the most effective and efficient methods to eliminate, reduce, or transfer such exposures. Operating decisions consider these associated risks and, whenever possible, transactions are structured to avoid or mitigate these risks.

From time to time, the Company enters into FX Forward Contracts to manage the exposure on forecasted transactions denominated in non-functional currencies and to manage the risk of transaction gains and losses associated with assets/liabilities in currencies other than the functional currency of certain subsidiaries. Certain of these FX Forward Contracts are designated as cash flow hedges. To the extent these derivatives are effective in offsetting the variability of the hedged cash flows, changes in the derivatives’ fair value are not included in current earnings but are included in accumulated other comprehensive income (loss) ("AOCI"). These changes in fair value are reclassified into earnings as a component of cost of sales, as applicable, when the forecasted transaction impacts earnings. In addition, if the forecasted transaction is no longer probable, the cumulative change in the derivatives’ fair value is recorded as a component of other income (expense) – net in the period in which the transaction is no longer considered probable of occurring. No amounts were recorded related to forecasted transactions no longer being probable during the three months ended March 31, 2024 and 2023.

The Company had FX Forward Contracts with aggregate notional amounts of $124.8 million and $140.1 million in U.S. dollar equivalent as of March 31, 2024 and December 31, 2023, respectively. The aggregate notional amount outstanding as of March 31, 2024, is scheduled to mature within one year. The FX Forward Contracts purchased are denominated in various foreign currencies. Net unrealized gains (losses), net of income tax, recorded in AOCI were $(0.3) million and $1.3 million as of March 31, 2024 and December 31, 2023, respectively.

The net gains (losses) recorded in the Condensed Consolidated Statements of Operations for FX Forward Contracts for the three months ended March 31, 2024 and 2023 are summarized as follows:

 

 

 

 

Three Months Ended
March 31,

 

 

 

Recognized Location

 

2024

 

 

2023

 

Designated

 

Cost of sales

 

$

(0.9

)

 

$

3.4

 

Non-Designated

 

Other income (expense) - net

 

$

1.4

 

 

$

(2.3

)

v3.24.1.u1
Inventories
3 Months Ended
Mar. 31, 2024
Inventory Disclosure [Abstract]  
Inventories

6. Inventories

The components of inventories as of March 31, 2024 and December 31, 2023 are summarized as follows:

 

 

March 31,
2024

 

 

December 31,
2023

 

Raw materials

 

$

203.4

 

 

$

164.7

 

Work-in-process

 

 

154.0

 

 

 

111.3

 

Finished goods

 

 

390.6

 

 

 

390.5

 

Total Inventories

 

$

748.0

 

 

$

666.5

 

 

v3.24.1.u1
Property, Plant and Equipment
3 Months Ended
Mar. 31, 2024
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment

7. Property, Plant, and Equipment

The components of property, plant, and equipment as of March 31, 2024 and December 31, 2023 are summarized as follows:

 

 

March 31,
2024

 

 

December 31,
2023

 

Land

 

$

14.7

 

 

$

14.9

 

Building and improvements

 

 

199.6

 

 

 

201.5

 

Machinery, equipment, and tooling

 

 

320.7

 

 

 

318.4

 

Furniture and fixtures

 

 

13.3

 

 

 

13.8

 

Computer hardware and software

 

 

134.8

 

 

 

135.8

 

Rental cranes

 

 

199.3

 

 

 

201.9

 

Construction in progress

 

 

6.7

 

 

 

7.2

 

Total cost

 

 

889.1

 

 

 

893.5

 

Less: accumulated depreciation

 

 

(531.6

)

 

 

(527.4

)

Property, plant, and equipment - net

 

$

357.5

 

 

$

366.1

 

Property, plant, and equipment is depreciated over the estimated useful life of the asset using the straight-line depreciation method for financial reporting and accelerated methods for income tax purposes.

Additions to property, plant, and equipment included in accounts payable and accrued expenses in the Condensed Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023 were $5.8 million and $7.0 million, respectively.

Assets Held for Sale

As of March 31, 2024 and December 31, 2023, the Company had $3.5 million and $3.0 million, respectively, of property, plant, and equipment classified as assets held for sale in other current assets in the Condensed Consolidated Balance Sheets. This amount relates to a manufacturing building and land in Fanzeres, Portugal.

v3.24.1.u1
Goodwill and Intangible Assets
3 Months Ended
Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Intangible Assets

8. Goodwill and Intangible Assets

The changes in the carrying amount of goodwill for the three months ended March 31, 2024 is summarized as follows:

 

 

Americas

 

 

MEAP

 

 

Consolidated

 

Balance as of December 31, 2023

 

$

14.4

 

 

$

65.2

 

 

$

79.6

 

Foreign currency impact

 

 

 

 

 

(0.9

)

 

 

(0.9

)

Balance as of March 31, 2024

 

$

14.4

 

 

$

64.3

 

 

$

78.7

 

The gross carrying amount, accumulated impairment and net book value of the Company's goodwill balances by reportable segment as of March 31, 2024 and December 31, 2023, are summarized as follows:

 

 

March 31, 2024

 

 

December 31, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Carrying Amount

 

 

Accumulated Impairment Amount

 

 

Net Book Value

 

 

Gross Carrying Amount

 

 

Accumulated Impairment Amount

 

Net Book Value

 

Americas

 

$

180.9

 

 

$

(166.5

)

 

$

14.4

 

 

$

180.9

 

 

$

(166.5

)

$

14.4

 

EURAF

 

 

82.2

 

 

 

(82.2

)

 

 

 

 

 

82.2

 

 

 

(82.2

)

 

 

MEAP

 

 

64.3

 

 

 

 

 

 

64.3

 

 

 

65.2

 

 

 

 

 

65.2

 

Total

 

$

327.4

 

 

$

(248.7

)

 

$

78.7

 

 

$

328.3

 

 

$

(248.7

)

$

79.6

 

The Company performs its annual goodwill impairment test during the fourth quarter, or more frequently if events or changes in circumstances indicate that there might be an impairment of the asset. The Company will continue to monitor changes in circumstances and test more frequently if those changes indicate that assets might be impaired. The Company determined there was no triggering event for the three months ended March 31, 2024.

The gross carrying amount, accumulated amortization, and net book value of the Company’s intangible assets other than goodwill as of March 31, 2024 and December 31, 2023, are summarized as follows:

 

 

March 31, 2024

 

 

December 31, 2023

 

 

 

Gross
Carrying
Amount

 

 

Accumulated
Amortization
Amount

 

 

Net
Book
Value

 

 

Gross
Carrying
Amount

 

 

Accumulated
Amortization
Amount

 

 

Net
Book
Value

 

Definite lived intangible assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Customer relationships

 

$

26.4

 

 

$

(12.0

)

 

$

14.4

 

 

$

26.5

 

 

$

(11.6

)

 

$

14.9

 

Patents

 

 

28.8

 

 

 

(28.4

)

 

 

0.4

 

 

 

29.2

 

 

 

(28.8

)

 

 

0.4

 

Noncompetition agreements

 

 

4.2

 

 

 

(2.2

)

 

 

2.0

 

 

 

4.2

 

 

 

(2.0

)

 

 

2.2

 

Trademarks and tradenames

 

 

2.2

 

 

 

(1.1

)

 

 

1.1

 

 

 

2.2

 

 

 

(1.0

)

 

 

1.2

 

Other intangibles

 

 

0.6

 

 

 

(0.6

)

 

 

 

 

 

0.7

 

 

 

(0.7

)

 

 

 

Total

 

$

62.2

 

 

$

(44.3

)

 

$

17.9

 

 

$

62.8

 

 

$

(44.1

)

 

$

18.7

 

Indefinite-lived intangible assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trademarks and tradenames

 

$

91.3

 

 

$

 

 

$

91.3

 

 

$

92.6

 

 

$

 

 

$

92.6

 

Distribution network

 

 

14.1

 

 

 

 

 

 

14.1

 

 

 

14.3

 

 

 

 

 

 

14.3

 

Total

 

 

105.4

 

 

 

 

 

 

105.4

 

 

 

106.9

 

 

 

 

 

 

106.9

 

Total intangible assets

 

$

167.6

 

 

$

(44.3

)

 

$

123.3

 

 

$

169.7

 

 

$

(44.1

)

 

$

125.6

 

The Company performs its annual indefinite-lived intangible assets impairment testing during the fourth quarter, or more frequently if events or changes in circumstances indicate that there might be an impairment of the asset. The Company will continue to monitor changes in circumstances and test more frequently if those changes indicate that assets might be impaired. The Company determined there was no triggering event for the three months ended March 31, 2024.

Definite lived intangible assets and long-lived assets are subject to impairment testing whenever events or circumstances indicate that the carrying value of the assets may not be recoverable. The Company determined there was no triggering event for the three months ended March 31, 2024.

Other intangible assets with definite lives are amortized over their estimated useful lives. Amortization expense for the three months ended March 31, 2024 and 2023 was $0.7 million and $1.0 million, respectively
v3.24.1.u1
Accounts Payable and Accrued Expenses
3 Months Ended
Mar. 31, 2024
Payables and Accruals [Abstract]  
Accounts Payable and Accrued Expenses

9. Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses as of March 31, 2024 and December 31, 2023 are summarized as follows:

 

 

 

March 31, 2024

 

 

December 31, 2023

 

Trade accounts payable

 

$

306.9

 

 

$

254.7

 

Employee-related expenses

 

 

47.0

 

 

 

57.9

 

Accrued vacation

 

 

24.7

 

 

 

23.7

 

Miscellaneous accrued expenses

 

 

130.8

 

 

 

121.1

 

Total accounts payable and accrued expenses

 

$

509.4

 

 

$

457.4

 

v3.24.1.u1
Debt
3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
Debt

10. Debt

Outstanding debt as of March 31, 2024 and December 31, 2023 is summarized as follows:

 

 

March 31, 2024

 

 

December 31, 2023

 

Borrowings under senior secured asset-based
   revolving credit facility

 

$

74.0

 

 

$

60.0

 

Senior secured second lien notes due 2026

 

 

300.0

 

 

 

300.0

 

Other debt

 

 

42.7

 

 

 

13.7

 

Deferred financing costs

 

 

(1.5

)

 

 

(1.6

)

Total debt

 

 

415.2

 

 

 

372.1

 

Short-term borrowings and current portion of long-term
   debt

 

 

(42.5

)

 

 

(13.4

)

Long-term debt

 

$

372.7

 

 

$

358.7

 

 

On March 25, 2019, the Company and certain subsidiaries of the Company (the “Loan Parties”) entered into a credit agreement (the “ABL Credit Agreement”) with JP Morgan Chase Bank, N.A. as administrative and collateral agent, and certain financial institutions party thereto as lenders, providing for a senior secured asset-based revolving credit facility (the “ABL Revolving Credit Facility”) of up to $275.0 million. The borrowing capacity under the ABL Revolving Credit Facility is based on the value of inventory, accounts receivable and certain fixed assets of the Loan Parties. The Loan Parties’ obligations under the ABL Revolving Credit Facility are secured on a first-priority basis, subject to certain exceptions and permitted liens, by substantially all of the personal property and fee-owned real property of the Loan Parties. The liens securing the ABL Revolving Credit Facility are senior in priority to the second-priority liens securing the obligations under the 2026 Notes and the related guarantees. The ABL Revolving Credit Facility includes a $75.0 million letter of credit sub-facility, $10.0 million of which is available to the Company’s German subsidiary that is a borrower under the ABL Revolving Credit Facility.

On June 17, 2021, the Company amended the ABL Credit Agreement to adjust certain negative covenants which reduced restrictions on the Company’s ability to expand its rental business. On May 19, 2022, the Company further amended the ABL Credit Agreement to (i) extend the maturity date to May 19, 2027 (subject to a springing maturity date of December 30, 2025 if the 2026 Notes have not been repaid in full or refinanced prior to December 30, 2025), (ii) permit the inclusion, subject to certain limitations, of the crane rental assets of certain subsidiaries in the borrowing base used to calculate availability under the ABL Credit Agreement, (iii) permit separate financing of crane rental assets not included in the borrowing base and (iv) replace U.S. dollar London Inter-bank Offered Rate with interest rates based on the secured overnight financing rate plus a credit spread adjustment (“SOFR”).

Borrowings under the ABL Revolving Credit Facility bear interest at a variable rate using either the Alternative Base Rate or SOFR plus the spread set forth below. The variable interest rate is based upon the average availability as of the most recent determination date as follows:

Average quarterly availability

Alternative base rate spread

SOFR spread

≥ 50% of Aggregate Commitment

0.25%

1.25%

< 50% of Aggregate Commitment

0.50%

1.50%

As of March 31, 2024 and December 31, 2023, the Company had borrowings on the ABL Revolving Credit Facility of $74.0 million and $60.0 million, respectively. As of March 31, 2024, the spreads for SOFR and Eurodollar, and Alternative Base Rate borrowings were 1.25% and 0.25%, respectively, with excess availability of approximately $197.6 million, which represents revolver borrowing capacity of $275.0 million less $74.0 million of borrowings outstanding and $3.4 million of U.S. letters of credit outstanding.

As of March 31, 2024, the Company had $42.7 million of other indebtedness outstanding that has a weighted-average interest rate of approximately 5.4%. This debt includes balances on local credit lines, overdraft facilities, and other financing arrangements.

On March 25, 2019, the Company and certain of its subsidiaries entered into an indenture with U.S. Bank National Association as trustee and notes collateral agent, pursuant to which the Company issued $300.0 million aggregate principal amount of the 2026 Notes with an annual coupon rate of 9.000%. Interest on the 2026 Notes is payable in cash semi-annually in arrears on April 1 and October 1 of each year. The 2026 Notes are fully and unconditionally guaranteed on a senior secured second lien basis, jointly and severally, by each of the Company’s existing and future domestic subsidiaries that is either a guarantor or a borrower under the ABL Revolving Credit Facility or that guarantees certain other debt of the Company or a guarantor. The 2026 Notes and the related guarantees are secured on a second-priority basis, subject to certain exceptions and permitted liens, by pledges of capital stock and other equity interests and other security interests in substantially all of the personal property and fee-owned real property of the Company and of the guarantors that secure obligations under the ABL Revolving Credit Facility.

Both the ABL Revolving Credit Facility and the 2026 Notes include customary covenants which include, without limitation, restrictions on, the Company’s ability and the ability of the Company’s restricted subsidiaries to incur, assume or guarantee additional debt or issue certain preferred shares, pay dividends on or make other distributions in respect of the Company’s capital stock or make other restricted payments, make certain investments, sell or transfer certain assets, create liens on certain assets to secure debt, consolidate, merge, sell, or otherwise dispose of all or substantially all of the Company’s assets, enter into certain transactions with affiliates and designate the Company’s subsidiaries as unrestricted. Both the ABL Revolving Credit Facility and the 2026 Notes also include customary events of default. The ABL Revolving Credit Facility has customary representations and warranties including, as a condition to borrowing, that all such representations and warranties are true and

correct, in all material respects, on the date of the borrowing, including representations as to no material adverse change in the Company’s business or financial condition since December 31, 2018.

Additionally, the ABL Revolving Credit Facility contains a covenant requiring the Company to maintain a minimum fixed charge coverage ratio under certain circumstances set forth in the ABL Credit Agreement.

As of March 31, 2024, the Company was in compliance with all affirmative and negative covenants in its debt instruments, inclusive of the financial covenants pertaining to the ABL Revolving Credit Facility and 2026 Notes. Based upon management’s current plans and outlook, the Company believes it will be able to comply with these covenants during the subsequent twelve months.
v3.24.1.u1
Accounts Receivable Factoring
3 Months Ended
Mar. 31, 2024
Transfers and Servicing [Abstract]  
Accounts Receivable Factoring

11. Accounts Receivable Factoring

The Company has two non-U.S. accounts receivable financing programs with no maximum availability. Transactions under the non-U.S. programs were accounted for as sales in accordance with Accounting Standards Codification (“ASC”) Topic 860, “Transfers and Servicing.” Under these financing programs, the Company has the ability to sell eligible receivables up to the maximum limit.

For the three months ended March 31, 2024 and 2023, cash proceeds from the factoring of accounts receivable qualifying as sales were $36.0 million.

Financing charges incurred from the factoring of accounts receivable qualifying as sales for the three months ended March 31, 2024 and 2023 were immaterial.

v3.24.1.u1
Income Taxes
3 Months Ended
Mar. 31, 2024
Income Tax Disclosure [Abstract]  
Income Taxes

12. Income Taxes

 

The Company’s income before income taxes include income from both U.S. and foreign jurisdictions. The annual effective tax rate varies from the U.S. federal statutory rate of 21% due to results of foreign operations that are subject to income taxes at different statutory rates. In addition, tax expense is impacted by losses in jurisdictions where no tax benefit can be realized.

For the three months ended March 31, 2024 and 2023, the Company recorded a provision for income taxes of $1.9 million and $4.2 million, respectively.

As of March 31, 2024 and December 31, 2023, the Company’s unrecognized tax benefits, excluding interest and penalties, were $9.2 million and $9.1 million, respectively.
v3.24.1.u1
Net Income Per Common Share
3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Net Income Per Share

13. Net Income Per Common Share

The following is a reconciliation of the weighted average shares outstanding used to compute basic and diluted net income per common share:

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

Basic weighted average common shares outstanding

 

 

35,265,449

 

 

 

35,121,473

 

Effect of dilutive securities - equity
   compensation awards

 

 

795,191

 

 

 

626,548

 

Diluted weighted average common shares outstanding

 

 

36,060,640

 

 

 

35,748,021

 

Equity compensation awards for which total employee proceeds from exercise exceed the average fair value of the same equity incentive instrument over the period have an anti-dilutive effect on earnings per share during periods with net income, and accordingly, are excluded from diluted weighted average common shares outstanding. Anti-dilutive equity instruments of 497,801 and 682,930 common shares were excluded from the computation of diluted net earnings per share for the three months ended March 31, 2024 and 2023, respectively.

No cash dividends were declared or paid during the three months ended March 31, 2024 and 2023.

v3.24.1.u1
Equity
3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Equity

14. Equity

Authorized capital consists of 75.0 million shares of $0.01 par value common stock and 3.5 million shares of $0.01 par value preferred stock. None of the preferred shares have been issued.

As of March 31, 2024, the Company has $35.0 million remaining under an authorization from the Board of Directors to purchase up to $35.0 million of the Company’s common stock at management’s discretion. The Company’s share repurchase program purchases shares in the open market to offset stock-based awards issued in conjunction with the Company’s 2013 Omnibus Incentive Plan.

A reconciliation of the changes in accumulated other comprehensive income (loss), net of income tax, by component for the three months ended March 31, 2024 and 2023 are summarized as follows:

 

 

Cash Flow Hedges

 

 

Pension &
Postretirement

 

 

Foreign Currency
Translation

 

 

Total

 

Balance as of December 31, 2022

 

$

5.4

 

 

$

(15.3

)

 

$

(98.0

)

 

$

(107.9

)

Other comprehensive income (loss) before
   reclassifications

 

 

0.1

 

 

 

(1.7

)

 

 

4.2

 

 

 

2.6

 

Amounts reclassified from accumulated other
   comprehensive income (loss)

 

 

(3.4

)

 

 

0.7

 

 

 

 

 

 

(2.7

)

Net other comprehensive income (loss)

 

 

(3.3

)

 

 

(1.0

)

 

 

4.2

 

 

 

(0.1

)

Balance as of March 31, 2023

 

$

2.1

 

 

$

(16.3

)

 

$

(93.8

)

 

$

(108.0

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of December 31, 2023

 

$

1.3

 

 

$

(10.3

)

 

$

(77.4

)

 

$

(86.4

)

Other comprehensive loss before
   reclassifications

 

 

(2.5

)

 

 

 

 

 

(11.0

)

 

 

(13.5

)

Amounts reclassified from accumulated other
   comprehensive income (loss)

 

 

0.9

 

 

 

0.1

 

 

 

 

 

 

1.0

 

Net other comprehensive income (loss)

 

 

(1.6

)

 

 

0.1

 

 

 

(11.0

)

 

 

(12.5

)

Balance as of March 31, 2024

 

$

(0.3

)

 

$

(10.2

)

 

$

(88.4

)

 

$

(98.9

)

A reconciliation of the reclassifications from accumulated other comprehensive loss, net of income tax, for the three months ended March 31, 2024 and 2023 are summarized as follows:

 

 

Amount Reclassified from Accumulated Other Comprehensive Loss

 

 

 

 

 

Three Months Ended March 31,
2024

 

 

Three Months Ended March 31,
2023

 

 

Recognized
Location

Gains (losses) on cash flow hedges

 

 

 

 

 

 

 

 

FX Forward Contracts

 

$

(0.9

)

 

$

3.4

 

 

Cost of sales

Total before income taxes

 

 

(0.9

)

 

 

3.4

 

 

 

Provision for income taxes

 

 

 

 

 

 

 

 

Total, net of income taxes

 

$

(0.9

)

 

$

3.4

 

 

 

Amortization of pension and
   postretirement items

 

 

 

 

 

 

 

 

Actuarial losses

 

$

(0.1

)

 

$

(1.0

)

(a)

Other income (expense) - net

Amortization of prior service cost

 

 

 

 

 

0.3

 

(a)

Other income (expense) - net

Total before income taxes

 

 

(0.1

)

 

 

(0.7

)

 

 

Provision for income taxes

 

 

 

 

 

 

 

 

Total, net of income taxes

 

$

(0.1

)

 

$

(0.7

)

 

 

 

 

 

 

 

 

 

 

 

Total reclassifications for the period,
   net of income taxes

 

$

(1.0

)

 

$

2.7

 

 

 

(a) These accumulated other comprehensive income (loss) components are components of net periodic pension cost (refer to Note 19, “Employee Benefit Plans,” for further details)

v3.24.1.u1
Stock-Based Compensation
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation

15. Stock-Based Compensation

Equity compensation awards may be granted to certain eligible employees or non-employee directors. A detailed description of the awards granted prior to 2024 is included in the Company’s 2023 Annual Report on Form 10-K. The total number of shares of the Company’s common stock available for awards under the Company’s 2013 Omnibus Incentive Plan is 7,477,395 shares. The total number of shares of the Company’s common stock still available for issuance as of March 31, 2024 is 2,338,858 shares.

Stock-based compensation expense was $3.7 million for the three months ended March 31, 2024 and $3.1 million for the three months ended March 31, 2023. The Company reports stock-based compensation expense within engineering, selling, and administrative expenses in the Condensed Consolidated Statements of Operations. The Company recognizes stock-based compensation expense over the award’s vesting period, subject to the retirement, death or disability provisions of the 2013 Omnibus Incentive Plan.

The Company granted 443,019 and 478,411 restricted stock units inclusive of 78,894 and 77,576 director awards during the three months ended March 31, 2024 and 2023, respectively. The restricted stock units granted to employees vest in three annual increments over a three-year period beginning on the grant date and director awards vest immediately on the grant date.

A total of 365,174 and 233,409 performance shares units were granted by the Company to employees during the three months ended March 31, 2024 and 2023, respectively. Performance share units vest after three years and are earned based on the extent to which performance goals are met over the applicable performance period. The performance goals and the applicable performance period vary for each grant year.

The performance goals for the performance share units granted in 2024 are weighted 60% on the 3-year average of the Company’s adjusted return on invested capital ("Adjusted ROIC") percentage from 2024 to 2026 and 40% on cumulative non-new machine sales from January 1, 2024 through December 31, 2026. The Company defines non-new machine sales as parts sales, used crane sales, rental revenue, service revenue and other revenue. The 2024 performance share units include a +/-20% modifier weighted on total shareholder return relative to a defined peer group of companies during the three-year performance period, not to exceed 200% of target shares granted.

The performance goals for the performance share units granted in 2023 are weighted 60% on the 3-year average of the Company’s adjusted EBITDA percentage from 2023 to 2025 and 40% on cumulative non-new machine sales from January 1, 2023 through December 31, 2025. The 2023 performance share units include a +/-20% modifier weighted on total shareholder return relative to a defined peer group of companies during the three-year performance period, not to exceed 200% of target shares granted.

v3.24.1.u1
Segments
3 Months Ended
Mar. 31, 2024
Segment Reporting [Abstract]  
Segments

16. Segments

The Company reports segment information based on the “management” approach. The management approach designates the internal reporting used by the Chief Executive Officer, who is also the Company’s Chief Operating Decision Maker (“CODM”), for making decisions about the allocation of resources and assessing performance as the source of the Company’s reportable operating segments.

The Company has three reportable segments: Americas, EURAF, and MEAP.

The CODM evaluates the performance of its reportable segments based on net sales and operating income. Segment net sales are recognized in the geographic region the product is sold. Operating income for each segment includes net sales to third parties, cost of sales directly attributable to the segment, and operating expenses directly attributable to the segment. Manufacturing variances generated within each operating segment are maintained in each segment’s operating income. Operating income for each segment excludes other income and expense and certain expenses managed outside the operating segments. Costs excluded from segment operating income include various corporate expenses such as stock-based compensation expense, income taxes, nonrecurring charges and other separately managed general and administrative costs. The Company does not include intercompany sales between segments for management reporting purposes. The Company’s operating segments were identified as its reportable segments. The CODM does not evaluate performance of the reportable segments based on total assets.

The following table shows information by reportable segment for the three months ended March 31, 2024 and 2023:

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

Net Sales

 

 

 

 

 

 

Americas

 

$

283.2

 

 

$

264.4

 

EURAF

 

 

143.0

 

 

 

178.2

 

MEAP

 

 

68.9

 

 

 

65.7

 

Total

 

$

495.1

 

 

$

508.3

 

Segment Operating Income (Loss)

 

 

 

 

 

 

Americas

 

$

29.5

 

 

$

28.5

 

EURAF

 

 

(11.8

)

 

 

3.6

 

MEAP

 

 

8.2

 

 

 

8.6

 

Total

 

$

25.9

 

 

$

40.7

 

Depreciation

 

 

 

 

 

 

Americas

 

$

7.3

 

 

$

7.2

 

EURAF

 

 

5.9

 

 

 

5.4

 

MEAP

 

 

0.8

 

 

 

0.6

 

Corporate

 

 

0.7

 

 

 

0.7

 

Total

 

$

14.7

 

 

$

13.9

 

Capital Expenditures

 

 

 

 

 

 

Americas

 

$

4.2

 

 

$

4.4

 

EURAF

 

 

7.2

 

 

 

4.7

 

MEAP

 

 

0.8

 

 

 

1.5

 

Corporate

 

 

 

 

 

 

Total

 

$

12.2

 

 

$

10.6

 

A reconciliation of the Company’s segment operating income to operating income in the Condensed Consolidated Statements of Operations for the three months ended March 31, 2024 and 2023 are summarized as follows:

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

Segment operating income

 

$

25.9

 

 

$

40.7

 

Unallocated corporate expenses

 

 

(10.7

)

 

 

(10.4

)

Unallocated restructuring expense

 

 

 

 

 

(0.1

)

Total operating income

 

$

15.2

 

 

$

30.2

 

Net sales by geographic area for the three months ended March 31, 2024 and 2023 are summarized as follows:

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

United States

 

$

249.2

 

 

$

213.8

 

Europe

 

 

138.2

 

 

 

174.4

 

Other

 

 

107.7

 

 

 

120.1

 

Total net sales

 

$

495.1

 

 

$

508.3

 

New machine and non-new machine sales for the three months ended March 31, 2024 and 2023 are summarized as follows:

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

New machine sales

 

$

349.9

 

 

$

357.3

 

Non-new machine sales

 

 

145.2

 

 

 

151.0

 

Total net sales

 

$

495.1

 

 

$

508.3

 

v3.24.1.u1
Commitments and Contingencies
3 Months Ended
Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

17. Commitments and Contingencies

The Company is subject to various legal proceedings and claims that have arisen in the ordinary course of business which have not been fully resolved. The outcome of any litigation is inherently uncertain. When a loss related to a legal proceeding or claim is probable and reasonably estimable, the Company accrues its best estimate for the ultimate resolution of the matter.

As of March 31, 2024, various product-related lawsuits were pending. To the extent permitted under applicable law, all of these lawsuits are insured with self-insurance retention levels. The Company’s self-insurance retention levels have varied over the last 10 years. As of March 31, 2024, the largest self-insured retention level for new occurrences currently maintained by the Company is $3.0 million per occurrence and applies to product liability claims arising in North America.

As of March 31, 2024, current and long-term product liability reserves were $4.1 million and $5.8 million, respectively. As of December 31, 2023, current and long-term product liability reserves were $11.4 million and $5.1 million, respectively. Current product liability reserves are included within other liabilities and long-term product liability reserves are included within other non-current liabilities in the Condensed Consolidated Balance Sheets. These amounts are not reduced for insurance recoveries for claims above the Company's self-insured retention level. As of March 31, 2024 and December 31, 2023, the Company had $0.5 million and $3.9 million, respectively, of estimated insurance recoveries included in other current assets in the Condensed Consolidated Balance Sheets.

Reserves for product-related lawsuits were estimated using a combination of actual case reserves and actuarial methods. Based on the Company’s experience in defending product liability claims, management believes the reserves are adequate for estimated case resolutions on aggregate self-insured claims and insured claims. Any recoveries from insurance carriers are dependent upon the legal sufficiency of claims and solvency of insurance carriers.

As of March 31, 2024 and December 31, 2023, the Company had reserves of $52.6 million and $56.8 million, respectively, for warranty and other related claims included in product warranties and other non-current liabilities in the Condensed Consolidated Balance Sheets. Certain of these warranty and other related claims involve matters in dispute that ultimately are resolved by negotiation, arbitration, or litigation. Refer to Note 18, “Guarantees,” for further information.

It is reasonably possible that the estimates for warranty and other related claims, product liability, asbestos-related claims, and other various legal matters may change based upon new information that may arise or matters that are beyond the scope of the Company’s historical experience. Presently, there are no reliable methods to estimate the amount of any such potential changes. The ultimate resolution of these matters, individually and in the aggregate, is not expected to have a material adverse effect on the Company’s financial condition, results of operations or cash flows.

 

In July 2017, the Company received an Information Request from the United States Environmental Protection Agency (“U.S. EPA”) relating to the sales of cranes manufactured between January 1, 2014 and July 31, 2017 and the Company’s related participation in the Transition Program for Equipment Manufacturers (the “TPEM” program). The TPEM program allowed equipment manufacturers to delay installing engines meeting Tier 4 final emission standards in their products, subject to certain percentage allowance restrictions. The Company has provided, and continues to provide, information to the U.S. EPA and the U.S. Department of Justice (“U.S. DOJ”) on the approximately 1,420 engines included in the Company’s cranes relating to the TPEM program and other certification matters. The Company is engaged in confidential discussions with the U.S. EPA and U.S. DOJ with respect to these matters.

 

Based on management's current assessment of the facts underlying these matters, the total recorded estimated liability in accounts payable and accrued expenses in the Company’s Condensed Consolidated Balance Sheets was $36.1 million as of March 31, 2024 and December 31, 2023. Other than the foregoing, the Company is unable to provide further meaningful quantification as to the final resolution of these matters. However, the Company calculated the statutory maximum penalties under the Clean Air Act to be approximately $174.0 million. The Company believes it has strong legal and factual defenses and will vigorously defend any allegations of noncompliance and the factors that could apply in the assessment of any civil penalty. Final resolution of these matters may have a material impact on the Company’s financial condition, results of operations or cash flows.

v3.24.1.u1
Guarantees
3 Months Ended
Mar. 31, 2024
Guarantees [Abstract]  
Guarantees

18. Guarantees

The Company periodically enters into transactions with customers that provide for buyback commitments. The Company evaluates each agreement at inception to determine if the customer has a significant economic incentive to exercise the buyback option. If it is determined that the customer has a significant economic incentive to exercise that right, the revenue is deferred and the agreement is accounted for as a lease in accordance with ASC Topic 842 – “Leases” (“Topic 842”). If it is determined that the customer does not have a significant economic incentive to exercise that right, then revenue is recognized when control

of the product is transferred to the customer. The revenue deferred related to buyback obligations accounted for under Topic 842 included in other current and non-current liabilities as of March 31, 2024 and December 31, 2023 was $30.4 million and $32.2 million, respectively. The total amount of buyback commitments given by the Company and outstanding as of March 31, 2024 and December 31, 2023 was $40.9 million and $43.4 million, respectively. These amounts are not reduced for amounts the Company would recover from the repossession and subsequent resale of the cranes. The buyback commitments expire at various times through 2032. The Company also has various loss guarantees with maximum liabilities of $13.5 million and $13.0 million as of March 31, 2024 and December 31, 2023, respectively. These amounts are not reduced for amounts the Company would recover from the repossession and subsequent resale of the cranes securing the related guarantees.

In the normal course of business, the Company provides its customers a warranty covering workmanship, and in some cases materials, on products manufactured by the Company. Such warranties generally provide that products will be free from defects for periods ranging from 12 months to 60 months. In addition, the Company may incur other warranty related costs outside of its standard warranty period. Costs for other warranty-related work are recorded in the period a loss is probable and can be reasonably estimated. Below is a table summarizing the warranty and other warranty related work for the three months ended March 31, 2024 and 2023.

 

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

Balance at beginning of period

 

$

56.8

 

 

$

58.0

 

Adjustments to accruals for warranties

 

 

5.3

 

 

 

6.6

 

Settlements made (in cash or in kind) during
   the period

 

 

(8.8

)

 

 

(8.5

)

Currency translation

 

 

(0.7

)

 

 

0.3

 

Balance at end of period

 

$

52.6

 

 

$

56.4

 

The long-term portion of the warranty liability is recorded in other non-current liabilities in the Condensed Consolidated Balance Sheets.

The revenue deferred related to extended warranty periods included in other current and non-current liabilities as of March 31, 2024 and December 31, 2023 was $7.3 million and $6.1 million, respectively.

v3.24.1.u1
Employee Benefit Plans
3 Months Ended
Mar. 31, 2024
Retirement Benefits [Abstract]  
Employee Benefit Plans

19. Employee Benefit Plans

The Company provides certain pension, health care, and death benefits to eligible retirees and their dependents. The funding mechanism for such benefits varies based on the country where the plan is located and the related plan. Eligibility for pension coverage is based on retirement qualifications. Healthcare benefits may be subject to deductibles, co-payments, and other limitations. The Company reserves the right to modify benefits unless prohibited by local laws or regulations.

The components of net periodic benefit cost for the three months ended March 31, 2024 and 2023 are summarized as follows:

 

 

Three Months Ended March 31, 2024

 

 

 

 

 

 

 

 

 

Postretirement

 

 

 

U.S.

 

 

Non-U.S.

 

 

Health and

 

 

 

Pension

 

 

Pension

 

 

Other

 

 

 

Plan

 

 

Plans

 

 

Plans

 

Service cost - benefits earned during the period

 

$

 

 

$

0.3

 

 

$

 

Interest cost of projected benefit obligations

 

 

1.3

 

 

 

0.7

 

 

 

0.1

 

Expected return on plan assets

 

 

(1.0

)

 

 

(0.4

)

 

 

 

Amortization of prior service cost

 

 

 

 

 

 

 

 

 

Amortization of actuarial net (gain) loss

 

 

0.5

 

 

 

 

 

 

(0.4

)

Net periodic benefit cost

 

$

0.8

 

 

$

0.6

 

 

$

(0.3

)

 

 

 

Three Months Ended March 31, 2023

 

 

 

 

 

 

 

 

 

Postretirement

 

 

 

U.S.

 

 

Non-U.S.

 

 

Health and

 

 

 

Pension

 

 

Pension

 

 

Other

 

 

 

Plan

 

 

Plans

 

 

Plans

 

Service cost - benefits earned during the period

 

$

 

 

$

0.3

 

 

$

 

Interest cost of projected benefit obligations

 

 

1.4

 

 

 

0.7

 

 

 

0.1

 

Expected return on plan assets

 

 

(1.0

)

 

 

(0.4

)

 

 

 

Amortization of prior service cost

 

 

 

 

 

 

 

 

(0.3

)

Amortization of actuarial net loss

 

 

0.6

 

 

 

0.4

 

 

 

 

Net periodic benefit cost

 

$

1.0

 

 

$

1.0

 

 

$

(0.2

)

The components of net periodic benefit cost other than the service cost component are included in other income (expense) - net in the Condensed Consolidated Statements of Operations.
v3.24.1.u1
Net Sales (Tables)
3 Months Ended
Mar. 31, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of Change In Customer Advances Balance The table below shows the change in the customer advances balance for the three months ended March 31, 2024 and 2023.

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

Balance at beginning of period

 

$

19.2

 

 

$

21.9

 

Cash received in advance of satisfying
   performance obligations

 

 

39.1

 

 

 

34.4

 

Revenue recognized

 

 

(37.7

)

 

 

(32.4

)

Currency translation

 

 

(0.3

)

 

 

0.1

 

Balance at end of period

 

$

20.3

 

 

$

24.0

 

v3.24.1.u1
Fair Value of Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Financial Assets and Liabilities Related to Foreign Currency Exchange Contracts Accounted for at Fair Value

The following table sets forth the Company’s financial assets and liabilities related to foreign currency exchange contracts ("FX Forward Contracts") and The Manitowoc Company, Inc. Deferred Compensation Plan (the "Deferred Compensation Plan") that were accounted for at fair value as of March 31, 2024 and December 31, 2023.

 

 

Fair Value as of March 31, 2024

 

 

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 

Recognized Location

Current Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FX Forward Contracts

 

$

 

 

$

0.3

 

 

$

 

 

$

0.3

 

 

 Other current assets

Deferred Compensation Plan - Program B

 

 

8.9

 

 

 

 

 

 

 

 

 

8.9

 

 

 Other non-current assets

Total current assets at fair value

 

$

8.9

 

 

$

0.3

 

 

$

 

 

$

9.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FX Forward Contracts

 

$

 

 

$

1.1

 

 

$

 

 

$

1.1

 

 

 Accounts payable and
   accrued expenses

 

 

 

Fair Value as of December 31, 2023

 

 

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 

Recognized Location

Current Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FX Forward Contracts

 

$

 

 

$

1.6

 

 

$

 

 

$

1.6

 

 

 Other current assets

Deferred Compensation Plan - Program B

 

 

8.1

 

 

 

 

 

 

 

 

 

8.1

 

 

 Other non-current assets

Total current assets at fair value

 

$

8.1

 

 

$

1.6

 

 

$

 

 

$

9.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FX Forward Contracts

 

$

 

 

$

0.6

 

 

$

 

 

$

0.6

 

 

 Accounts payable and
   accrued expenses

v3.24.1.u1
Derivative Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2024
Foreign Currency Exchange Contracts  
Derivative Instruments Gain Loss [Line Items]  
Summary of Gains or Losses Recorded in Condensed Consolidated Statement of Operations for FX Forward Contracts

The net gains (losses) recorded in the Condensed Consolidated Statements of Operations for FX Forward Contracts for the three months ended March 31, 2024 and 2023 are summarized as follows:

 

 

 

 

Three Months Ended
March 31,

 

 

 

Recognized Location

 

2024

 

 

2023

 

Designated

 

Cost of sales

 

$

(0.9

)

 

$

3.4

 

Non-Designated

 

Other income (expense) - net

 

$

1.4

 

 

$

(2.3

)

v3.24.1.u1
Inventories (Tables)
3 Months Ended
Mar. 31, 2024
Inventory Disclosure [Abstract]  
Schedule of the components of inventories

The components of inventories as of March 31, 2024 and December 31, 2023 are summarized as follows:

 

 

March 31,
2024

 

 

December 31,
2023

 

Raw materials

 

$

203.4

 

 

$

164.7

 

Work-in-process

 

 

154.0

 

 

 

111.3

 

Finished goods

 

 

390.6

 

 

 

390.5

 

Total Inventories

 

$

748.0

 

 

$

666.5

 

 

v3.24.1.u1
Property, Plant and Equipment (Tables)
3 Months Ended
Mar. 31, 2024
Property, Plant and Equipment [Abstract]  
Components of Property, Plant and Equipment

The components of property, plant, and equipment as of March 31, 2024 and December 31, 2023 are summarized as follows:

 

 

March 31,
2024

 

 

December 31,
2023

 

Land

 

$

14.7

 

 

$

14.9

 

Building and improvements

 

 

199.6

 

 

 

201.5

 

Machinery, equipment, and tooling

 

 

320.7

 

 

 

318.4

 

Furniture and fixtures

 

 

13.3

 

 

 

13.8

 

Computer hardware and software

 

 

134.8

 

 

 

135.8

 

Rental cranes

 

 

199.3

 

 

 

201.9

 

Construction in progress

 

 

6.7

 

 

 

7.2

 

Total cost

 

 

889.1

 

 

 

893.5

 

Less: accumulated depreciation

 

 

(531.6

)

 

 

(527.4

)

Property, plant, and equipment - net

 

$

357.5

 

 

$

366.1

 

v3.24.1.u1
Goodwill and Intangible Assets (Tables)
3 Months Ended
Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Changes in goodwill by reportable segment

The changes in the carrying amount of goodwill for the three months ended March 31, 2024 is summarized as follows:

 

 

Americas

 

 

MEAP

 

 

Consolidated

 

Balance as of December 31, 2023

 

$

14.4

 

 

$

65.2

 

 

$

79.6

 

Foreign currency impact

 

 

 

 

 

(0.9

)

 

 

(0.9

)

Balance as of March 31, 2024

 

$

14.4

 

 

$

64.3

 

 

$

78.7

 

Schedule of Goodwill Balances by Reporting Unit

The gross carrying amount, accumulated impairment and net book value of the Company's goodwill balances by reportable segment as of March 31, 2024 and December 31, 2023, are summarized as follows:

 

 

March 31, 2024

 

 

December 31, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Carrying Amount

 

 

Accumulated Impairment Amount

 

 

Net Book Value

 

 

Gross Carrying Amount

 

 

Accumulated Impairment Amount

 

Net Book Value

 

Americas

 

$

180.9

 

 

$

(166.5

)

 

$

14.4

 

 

$

180.9

 

 

$

(166.5

)

$

14.4

 

EURAF

 

 

82.2

 

 

 

(82.2

)

 

 

 

 

 

82.2

 

 

 

(82.2

)

 

 

MEAP

 

 

64.3

 

 

 

 

 

 

64.3

 

 

 

65.2

 

 

 

 

 

65.2

 

Total

 

$

327.4

 

 

$

(248.7

)

 

$

78.7

 

 

$

328.3

 

 

$

(248.7

)

$

79.6

 

Gross carrying amount, accumulated amortization and net book value of intangible assets other than goodwill

The gross carrying amount, accumulated amortization, and net book value of the Company’s intangible assets other than goodwill as of March 31, 2024 and December 31, 2023, are summarized as follows:

 

 

March 31, 2024

 

 

December 31, 2023

 

 

 

Gross
Carrying
Amount

 

 

Accumulated
Amortization
Amount

 

 

Net
Book
Value

 

 

Gross
Carrying
Amount

 

 

Accumulated
Amortization
Amount

 

 

Net
Book
Value

 

Definite lived intangible assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Customer relationships

 

$

26.4

 

 

$

(12.0

)

 

$

14.4

 

 

$

26.5

 

 

$

(11.6

)

 

$

14.9

 

Patents

 

 

28.8

 

 

 

(28.4

)

 

 

0.4

 

 

 

29.2

 

 

 

(28.8

)

 

 

0.4

 

Noncompetition agreements

 

 

4.2

 

 

 

(2.2

)

 

 

2.0

 

 

 

4.2

 

 

 

(2.0

)

 

 

2.2

 

Trademarks and tradenames

 

 

2.2

 

 

 

(1.1

)

 

 

1.1

 

 

 

2.2

 

 

 

(1.0

)

 

 

1.2

 

Other intangibles

 

 

0.6

 

 

 

(0.6

)

 

 

 

 

 

0.7

 

 

 

(0.7

)

 

 

 

Total

 

$

62.2

 

 

$

(44.3

)

 

$

17.9

 

 

$

62.8

 

 

$

(44.1

)

 

$

18.7

 

Indefinite-lived intangible assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trademarks and tradenames

 

$

91.3

 

 

$

 

 

$

91.3

 

 

$

92.6

 

 

$

 

 

$

92.6

 

Distribution network

 

 

14.1

 

 

 

 

 

 

14.1

 

 

 

14.3

 

 

 

 

 

 

14.3

 

Total

 

 

105.4

 

 

 

 

 

 

105.4

 

 

 

106.9

 

 

 

 

 

 

106.9

 

Total intangible assets

 

$

167.6

 

 

$

(44.3

)

 

$

123.3

 

 

$

169.7

 

 

$

(44.1

)

 

$

125.6

 

v3.24.1.u1
Accounts Payable and Accrued Expenses (Tables)
3 Months Ended
Mar. 31, 2024
Payables and Accruals [Abstract]  
Schedule of accounts payable and accrued expenses

Accounts payable and accrued expenses as of March 31, 2024 and December 31, 2023 are summarized as follows:

 

 

 

March 31, 2024

 

 

December 31, 2023

 

Trade accounts payable

 

$

306.9

 

 

$

254.7

 

Employee-related expenses

 

 

47.0

 

 

 

57.9

 

Accrued vacation

 

 

24.7

 

 

 

23.7

 

Miscellaneous accrued expenses

 

 

130.8

 

 

 

121.1

 

Total accounts payable and accrued expenses

 

$

509.4

 

 

$

457.4

 

v3.24.1.u1
Debt (Tables)
3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
Schedule of outstanding debt

Outstanding debt as of March 31, 2024 and December 31, 2023 is summarized as follows:

 

 

March 31, 2024

 

 

December 31, 2023

 

Borrowings under senior secured asset-based
   revolving credit facility

 

$

74.0

 

 

$

60.0

 

Senior secured second lien notes due 2026

 

 

300.0

 

 

 

300.0

 

Other debt

 

 

42.7

 

 

 

13.7

 

Deferred financing costs

 

 

(1.5

)

 

 

(1.6

)

Total debt

 

 

415.2

 

 

 

372.1

 

Short-term borrowings and current portion of long-term
   debt

 

 

(42.5

)

 

 

(13.4

)

Long-term debt

 

$

372.7

 

 

$

358.7

 

 

Schedule of revolving credit facility bear interest at variable rate based upon average quarterly availability

Average quarterly availability

Alternative base rate spread

SOFR spread

≥ 50% of Aggregate Commitment

0.25%

1.25%

< 50% of Aggregate Commitment

0.50%

1.50%

v3.24.1.u1
Net Income Per Common Share (Tables)
3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Reconciliation of the weighted average common shares outstanding used to compute basic and diluted net income (loss) per common share

The following is a reconciliation of the weighted average shares outstanding used to compute basic and diluted net income per common share:

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

Basic weighted average common shares outstanding

 

 

35,265,449

 

 

 

35,121,473

 

Effect of dilutive securities - equity
   compensation awards

 

 

795,191

 

 

 

626,548

 

Diluted weighted average common shares outstanding

 

 

36,060,640

 

 

 

35,748,021

 

v3.24.1.u1
Equity (Tables)
3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Schedule of Components of Accumulated Other Comprehensive Income (Loss)

A reconciliation of the changes in accumulated other comprehensive income (loss), net of income tax, by component for the three months ended March 31, 2024 and 2023 are summarized as follows:

 

 

Cash Flow Hedges

 

 

Pension &
Postretirement

 

 

Foreign Currency
Translation

 

 

Total

 

Balance as of December 31, 2022

 

$

5.4

 

 

$

(15.3

)

 

$

(98.0

)

 

$

(107.9

)

Other comprehensive income (loss) before
   reclassifications

 

 

0.1

 

 

 

(1.7

)

 

 

4.2

 

 

 

2.6

 

Amounts reclassified from accumulated other
   comprehensive income (loss)

 

 

(3.4

)

 

 

0.7

 

 

 

 

 

 

(2.7

)

Net other comprehensive income (loss)

 

 

(3.3

)

 

 

(1.0

)

 

 

4.2

 

 

 

(0.1

)

Balance as of March 31, 2023

 

$

2.1

 

 

$

(16.3

)

 

$

(93.8

)

 

$

(108.0

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of December 31, 2023

 

$

1.3

 

 

$

(10.3

)

 

$

(77.4

)

 

$

(86.4

)

Other comprehensive loss before
   reclassifications

 

 

(2.5

)

 

 

 

 

 

(11.0

)

 

 

(13.5

)

Amounts reclassified from accumulated other
   comprehensive income (loss)

 

 

0.9

 

 

 

0.1

 

 

 

 

 

 

1.0

 

Net other comprehensive income (loss)

 

 

(1.6

)

 

 

0.1

 

 

 

(11.0

)

 

 

(12.5

)

Balance as of March 31, 2024

 

$

(0.3

)

 

$

(10.2

)

 

$

(88.4

)

 

$

(98.9

)

Reconciliation of Reclassifications From Accumulated Other Comprehensive Income (Loss), Net of Income Tax

A reconciliation of the reclassifications from accumulated other comprehensive loss, net of income tax, for the three months ended March 31, 2024 and 2023 are summarized as follows:

 

 

Amount Reclassified from Accumulated Other Comprehensive Loss

 

 

 

 

 

Three Months Ended March 31,
2024

 

 

Three Months Ended March 31,
2023

 

 

Recognized
Location

Gains (losses) on cash flow hedges

 

 

 

 

 

 

 

 

FX Forward Contracts

 

$

(0.9

)

 

$

3.4

 

 

Cost of sales

Total before income taxes

 

 

(0.9

)

 

 

3.4

 

 

 

Provision for income taxes

 

 

 

 

 

 

 

 

Total, net of income taxes

 

$

(0.9

)

 

$

3.4

 

 

 

Amortization of pension and
   postretirement items

 

 

 

 

 

 

 

 

Actuarial losses

 

$

(0.1

)

 

$

(1.0

)

(a)

Other income (expense) - net

Amortization of prior service cost

 

 

 

 

 

0.3

 

(a)

Other income (expense) - net

Total before income taxes

 

 

(0.1

)

 

 

(0.7

)

 

 

Provision for income taxes

 

 

 

 

 

 

 

 

Total, net of income taxes

 

$

(0.1

)

 

$

(0.7

)

 

 

 

 

 

 

 

 

 

 

 

Total reclassifications for the period,
   net of income taxes

 

$

(1.0

)

 

$

2.7

 

 

 

(a) These accumulated other comprehensive income (loss) components are components of net periodic pension cost (refer to Note 19, “Employee Benefit Plans,” for further details)

v3.24.1.u1
Segments (Tables)
3 Months Ended
Mar. 31, 2024
Segment Reporting [Abstract]  
Schedule of Information by Reportable Segment

The following table shows information by reportable segment for the three months ended March 31, 2024 and 2023:

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

Net Sales

 

 

 

 

 

 

Americas

 

$

283.2

 

 

$

264.4

 

EURAF

 

 

143.0

 

 

 

178.2

 

MEAP

 

 

68.9

 

 

 

65.7

 

Total

 

$

495.1

 

 

$

508.3

 

Segment Operating Income (Loss)

 

 

 

 

 

 

Americas

 

$

29.5

 

 

$

28.5

 

EURAF

 

 

(11.8

)

 

 

3.6

 

MEAP

 

 

8.2

 

 

 

8.6

 

Total

 

$

25.9

 

 

$

40.7

 

Depreciation

 

 

 

 

 

 

Americas

 

$

7.3

 

 

$

7.2

 

EURAF

 

 

5.9

 

 

 

5.4

 

MEAP

 

 

0.8

 

 

 

0.6

 

Corporate

 

 

0.7

 

 

 

0.7

 

Total

 

$

14.7

 

 

$

13.9

 

Capital Expenditures

 

 

 

 

 

 

Americas

 

$

4.2

 

 

$

4.4

 

EURAF

 

 

7.2

 

 

 

4.7

 

MEAP

 

 

0.8

 

 

 

1.5

 

Corporate

 

 

 

 

 

 

Total

 

$

12.2

 

 

$

10.6

 

Schedule of Reconciliation of the Company's Segment Operating Income

A reconciliation of the Company’s segment operating income to operating income in the Condensed Consolidated Statements of Operations for the three months ended March 31, 2024 and 2023 are summarized as follows:

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

Segment operating income

 

$

25.9

 

 

$

40.7

 

Unallocated corporate expenses

 

 

(10.7

)

 

 

(10.4

)

Unallocated restructuring expense

 

 

 

 

 

(0.1

)

Total operating income

 

$

15.2

 

 

$

30.2

 

Schedule of Net Sales by Geographic Area

Net sales by geographic area for the three months ended March 31, 2024 and 2023 are summarized as follows:

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

United States

 

$

249.2

 

 

$

213.8

 

Europe

 

 

138.2

 

 

 

174.4

 

Other

 

 

107.7

 

 

 

120.1

 

Total net sales

 

$

495.1

 

 

$

508.3

 

Schedule of Net Sales By Product

New machine and non-new machine sales for the three months ended March 31, 2024 and 2023 are summarized as follows:

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

New machine sales

 

$

349.9

 

 

$

357.3

 

Non-new machine sales

 

 

145.2

 

 

 

151.0

 

Total net sales

 

$

495.1

 

 

$

508.3

 

v3.24.1.u1
Guarantees (Tables)
3 Months Ended
Mar. 31, 2024
Guarantees [Abstract]  
Summary of Warranty Activity Below is a table summarizing the warranty and other warranty related work for the three months ended March 31, 2024 and 2023.

 

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

Balance at beginning of period

 

$

56.8

 

 

$

58.0

 

Adjustments to accruals for warranties

 

 

5.3

 

 

 

6.6

 

Settlements made (in cash or in kind) during
   the period

 

 

(8.8

)

 

 

(8.5

)

Currency translation

 

 

(0.7

)

 

 

0.3

 

Balance at end of period

 

$

52.6

 

 

$

56.4

 

v3.24.1.u1
Employee Benefit Plans (Tables)
3 Months Ended
Mar. 31, 2024
Retirement Benefits [Abstract]  
Schedule of components of net periodic benefit costs

The components of net periodic benefit cost for the three months ended March 31, 2024 and 2023 are summarized as follows:

 

 

Three Months Ended March 31, 2024

 

 

 

 

 

 

 

 

 

Postretirement

 

 

 

U.S.

 

 

Non-U.S.

 

 

Health and

 

 

 

Pension

 

 

Pension

 

 

Other

 

 

 

Plan

 

 

Plans

 

 

Plans

 

Service cost - benefits earned during the period

 

$

 

 

$

0.3

 

 

$

 

Interest cost of projected benefit obligations

 

 

1.3

 

 

 

0.7

 

 

 

0.1

 

Expected return on plan assets

 

 

(1.0

)

 

 

(0.4

)

 

 

 

Amortization of prior service cost

 

 

 

 

 

 

 

 

 

Amortization of actuarial net (gain) loss

 

 

0.5

 

 

 

 

 

 

(0.4

)

Net periodic benefit cost

 

$

0.8

 

 

$

0.6

 

 

$

(0.3

)

 

 

 

Three Months Ended March 31, 2023

 

 

 

 

 

 

 

 

 

Postretirement

 

 

 

U.S.

 

 

Non-U.S.

 

 

Health and

 

 

 

Pension

 

 

Pension

 

 

Other

 

 

 

Plan

 

 

Plans

 

 

Plans

 

Service cost - benefits earned during the period

 

$

 

 

$

0.3

 

 

$

 

Interest cost of projected benefit obligations

 

 

1.4

 

 

 

0.7

 

 

 

0.1

 

Expected return on plan assets

 

 

(1.0

)

 

 

(0.4

)

 

 

 

Amortization of prior service cost

 

 

 

 

 

 

 

 

(0.3

)

Amortization of actuarial net loss

 

 

0.6

 

 

 

0.4

 

 

 

 

Net periodic benefit cost

 

$

1.0

 

 

$

1.0

 

 

$

(0.2

)

v3.24.1.u1
Company and Basis of Presentation - Narrative (Details)
3 Months Ended
Mar. 31, 2024
Segment
Accounting Policies [Abstract]  
Period of providing high-quality, customer-focused products and support services 120 years
Number of reportable segments 3
v3.24.1.u1
Net Sales - Schedule of Change In Customer Advances Balance (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue from Contract with Customer [Abstract]    
Balance at beginning of period $ 19.2 $ 21.9
Cash received in advance of satisfying performance obligations 39.1 34.4
Revenue recognized (37.7) (32.4)
Currency translation (0.3) 0.1
Balance at end of period $ 20.3 $ 24.0
v3.24.1.u1
Fair Value of Financial Instruments - Financial Assets and Liabilities Related to Foreign Currency Exchange Contracts Account for at Fair Value (Details) - Estimate of Fair Value Measurement - Fair Value, Measurements, Recurring - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Derivatives assets, current $ 9.2 $ 9.7
Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration] Other Assets, Current Other Assets, Current
Level 1    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Derivatives assets, current $ 8.9 $ 8.1
Level 2    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Derivatives assets, current 0.3 1.6
Level 3    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Derivatives assets, current 0.0 0.0
Foreign Currency Exchange Contracts    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Derivatives assets, current 0.3 1.6
Derivative liabilities, current 1.1 0.6
Foreign Currency Exchange Contracts | Level 1    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Derivatives assets, current 0.0 0.0
Derivative liabilities, current 0.0 0.0
Foreign Currency Exchange Contracts | Level 2    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Derivatives assets, current 0.3 1.6
Derivative liabilities, current 1.1 0.6
Foreign Currency Exchange Contracts | Level 3    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Derivatives assets, current 0.0 0.0
Derivative liabilities, current 0.0 0.0
Deferred Compensation Plan - Program B    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Derivatives assets, current 8.9 8.1
Deferred Compensation Plan - Program B | Level 1    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Derivatives assets, current 8.9 8.1
Deferred Compensation Plan - Program B | Level 2    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Derivatives assets, current 0.0 0.0
Deferred Compensation Plan - Program B | Level 3    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Derivatives assets, current $ 0.0 $ 0.0
v3.24.1.u1
Fair Value of Financial Instruments - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Mar. 25, 2019
Senior Notes Due 2026      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Debt instruments at fair value $ 300.2 $ 302.7  
Interest rate, stated percentage (as a percent) 9.00%   9.00%
Debt instrument maturity date Apr. 01, 2026    
Senior secured second lien notes      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Debt instruments at fair value $ 300.0    
v3.24.1.u1
Derivative Financial Instruments - Narrative (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Derivatives Fair Value [Line Items]    
Unrealized gain (losses) net of income tax $ (0.3) $ 1.3
Foreign Exchange Forward    
Derivatives Fair Value [Line Items]    
Derivative, notional amount $ 124.8 $ 140.1
Derivative remaining maturity period 1 year  
v3.24.1.u1
Derivative Financial Instruments - Summary of Gain or Losses Recorded in Condensed Consolidated Statement of Operations for FX Forward Contracts (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Designated | Cost of Sales    
Derivative Instruments Gain Loss [Line Items]    
Gains (loss) on foreign currency exchange contracts $ (0.9) $ 3.4
Non-Designated | Other Income (Expense) - Net    
Derivative Instruments Gain Loss [Line Items]    
Gains (loss) on foreign currency exchange contracts $ 1.4 $ (2.3)
v3.24.1.u1
Inventories - Components of Inventories (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Inventory Disclosure [Abstract]    
Raw materials $ 203.4 $ 164.7
Work-in-process 154.0 111.3
Finished goods 390.6 390.5
Total Inventories $ 748.0 $ 666.5
v3.24.1.u1
Notes Receivable - Narrative (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Receivables [Abstract]    
Notes receivable, current $ 5.7 $ 6.7
v3.24.1.u1
Property, Plant and Equipment - Components of property, plant and equipment (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Property, Plant and Equipment    
Total cost $ 889.1 $ 893.5
Less accumulated depreciation (531.6) (527.4)
Property, plant and equipment — net 357.5 366.1
Land    
Property, Plant and Equipment    
Total cost 14.7 14.9
Building and Improvements    
Property, Plant and Equipment    
Total cost 199.6 201.5
Machinery, Equipment, and Tooling    
Property, Plant and Equipment    
Total cost 320.7 318.4
Furniture and Fixtures    
Property, Plant and Equipment    
Total cost 13.3 13.8
Computer Hardware and Software    
Property, Plant and Equipment    
Total cost 134.8 135.8
Rental cranes    
Property, Plant and Equipment    
Total cost 199.3 201.9
Construction in Progress    
Property, Plant and Equipment    
Total cost $ 6.7 $ 7.2
v3.24.1.u1
Property, Plant and Equipment - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Property, Plant and Equipment    
Additions of property, plant and equipment $ 5.8 $ 7.0
Other Current Assets    
Property, Plant and Equipment    
Assets held for sale $ 3.5 $ 3.0
v3.24.1.u1
Goodwill and Intangible Assets - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Goodwill [Line Items]    
Amortization of intangible assets $ 0.7 $ 1.0
v3.24.1.u1
Goodwill and Intangible Assets - Changes in goodwill by reportable segment (Details)
$ in Millions
3 Months Ended
Mar. 31, 2024
USD ($)
Goodwill  
Balance at the beginning of the period $ 79.6
Foreign currency impact (0.9)
Balance at the end of the period 78.7
Americas  
Goodwill  
Balance at the beginning of the period 14.4
Foreign currency impact 0.0
Balance at the end of the period 14.4
Middle East and Asia Pacific ("MEAP")  
Goodwill  
Balance at the beginning of the period 65.2
Foreign currency impact (0.9)
Balance at the end of the period $ 64.3
v3.24.1.u1
Goodwill and Intangible Assets - Schedule of Goodwill Balances by Reporting Unit (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Goodwill [Line Items]    
Gross Amount $ 327.4 $ 328.3
Accumulated Impairment Amount (248.7) (248.7)
Net Amount 78.7 79.6
Americas    
Goodwill [Line Items]    
Gross Amount 180.9 180.9
Accumulated Impairment Amount (166.5) (166.5)
Net Amount 14.4 14.4
EURAF    
Goodwill [Line Items]    
Gross Amount 82.2 82.2
Accumulated Impairment Amount (82.2) (82.2)
Net Amount 0.0 0.0
MEAP    
Goodwill [Line Items]    
Gross Amount 64.3 65.2
Accumulated Impairment Amount 0.0 0.0
Net Amount $ 64.3 $ 65.2
v3.24.1.u1
Goodwill and Intangible Assets - Gross carrying amount and accumulated amortization of the company's intangible assets other than goodwill (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Intangible asset balances by major asset class    
Intangible assets, gross (excluding goodwill) $ 167.6 $ 169.7
Finite-lived intangible assets, amortization amount (44.3) (44.1)
Intangible assets, book value 123.3 125.6
Indefinite-lived Intangible Assets    
Intangible asset balances by major asset class    
Intangible assets, gross (excluding goodwill) 105.4 106.9
Finite-lived intangible assets, amortization amount 0.0 0.0
Intangible assets, book value 105.4 106.9
Indefinite-lived Intangible Assets | Distribution Network    
Intangible asset balances by major asset class    
Indefinite-lived intangible assets, book value 14.1 14.3
Finite-lived intangible assets, amortization amount 0.0 0.0
Indefinite-lived Intangible Assets | Trademarks and Tradenames    
Intangible asset balances by major asset class    
Indefinite-lived intangible assets, book value 91.3 92.6
Finite-lived intangible assets, amortization amount 0.0 0.0
Finite-Lived Intangible Assets    
Intangible asset balances by major asset class    
Finite-lived intangible assets, carrying amount 62.2 62.8
Finite-lived intangible assets, amortization amount (44.3) (44.1)
Finite-lived intangible assets, book value 17.9 18.7
Finite-Lived Intangible Assets | Customer Relationships    
Intangible asset balances by major asset class    
Finite-lived intangible assets, carrying amount 26.4 26.5
Finite-lived intangible assets, amortization amount (12.0) (11.6)
Finite-lived intangible assets, book value 14.4 14.9
Finite-Lived Intangible Assets | Patents    
Intangible asset balances by major asset class    
Finite-lived intangible assets, carrying amount 28.8 29.2
Finite-lived intangible assets, amortization amount (28.4) (28.8)
Finite-lived intangible assets, book value 0.4 0.4
Finite-Lived Intangible Assets | Noncompetition Agreements    
Intangible asset balances by major asset class    
Finite-lived intangible assets, carrying amount 4.2 4.2
Finite-lived intangible assets, amortization amount (2.2) (2.0)
Finite-lived intangible assets, book value 2.0 2.2
Finite-Lived Intangible Assets | Other Intangibles    
Intangible asset balances by major asset class    
Finite-lived intangible assets, carrying amount 0.6 0.7
Finite-lived intangible assets, amortization amount (0.6) (0.7)
Finite-lived intangible assets, book value 0.0 0.0
Finite-Lived Intangible Assets | Trademarks and Tradenames    
Intangible asset balances by major asset class    
Finite-lived intangible assets, carrying amount 2.2 2.2
Finite-lived intangible assets, amortization amount (1.1) (1.0)
Finite-lived intangible assets, book value $ 1.1 $ 1.2
v3.24.1.u1
Accounts Payable and Accrued Expenses - Schedule of Accounts Payable and Accured Expenses (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Payables and Accruals [Abstract]    
Trade accounts payable $ 306.9 $ 254.7
Employee-related expenses 47.0 57.9
Accrued vacation 24.7 23.7
Miscellaneous accrued expenses 130.8 121.1
Total accounts payable and accrued expenses $ 509.4 $ 457.4
v3.24.1.u1
Debt - Schedule of outstanding debt (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Debt Instrument [Line Items]    
Total debt $ 415.2 $ 372.1
Deferred financing costs (1.5) (1.6)
Short-term borrowings and current portion of long-term debt (42.5) (13.4)
Long-term debt 372.7 358.7
ABL Revolving Credit Facility    
Debt Instrument [Line Items]    
Borrowings under senior secured asset based revolving credit facility 74.0 60.0
Senior Secured Second Lien Notes Due 2026    
Debt Instrument [Line Items]    
Total debt 300.0 300.0
Other Debt    
Debt Instrument [Line Items]    
Total debt $ 42.7 $ 13.7
v3.24.1.u1
Debt - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 25, 2019
Mar. 31, 2024
Dec. 31, 2023
Debt Instrument [Line Items]      
Carrying amount   $ 415.2 $ 372.1
Period for which the entity will be able to comply with the financial covenants   12 months  
Senior Notes Due 2026      
Debt Instrument [Line Items]      
Face amount of debt $ 300.0    
Debt instrument interest rate 9.00% 9.00%  
Interest on the notes Interest on the 2026 Notes is payable in cash semi-annually in arrears on April 1 and October 1 of each year.    
ABL Revolving Credit Facility      
Debt Instrument [Line Items]      
Maximum borrowing capacity under revolving credit facility $ 275.0    
Line of credit outstanding   $ 74.0 60.0
Excess capacity   197.6  
Line of credit borrowing capacity   $ 275.0  
ABL Revolving Credit Facility | SOFR Spread      
Debt Instrument [Line Items]      
Basis spread on variable rate (as a percent)   1.25%  
ABL Revolving Credit Facility | Base Rate      
Debt Instrument [Line Items]      
Basis spread on variable rate (as a percent)   0.25%  
ABL Revolving Credit Facility | Letter of Credit      
Debt Instrument [Line Items]      
Maximum borrowing capacity under revolving credit facility 75.0    
Line of credit outstanding   $ 3.4  
ABL Revolving Credit Facility | Letter of Credit | German Borrowers      
Debt Instrument [Line Items]      
Maximum borrowing capacity under revolving credit facility $ 10.0    
Other      
Debt Instrument [Line Items]      
Carrying amount   $ 42.7 $ 13.7
Weighted average interest rate (as a percent)   5.40%  
v3.24.1.u1
Debt - Schedule of Revolving Credit Facility Bear Interest at Variable Rate Based Upon Average Quarterly Availability (Details) - ABL Revolving Credit Facility
3 Months Ended
Mar. 31, 2024
SOFR Spread  
Debt Instrument [Line Items]  
Basis spread on variable rate (as a percent) 1.25%
Greater Than or Equal to 50% of Aggregate Commitment | Alternative Base Rate Spread  
Debt Instrument [Line Items]  
Basis spread on variable rate (as a percent) 0.25%
Greater Than or Equal to 50% of Aggregate Commitment | SOFR Spread  
Debt Instrument [Line Items]  
Basis spread on variable rate (as a percent) 1.25%
Less Than 50% of Aggregate Commitment | Alternative Base Rate Spread  
Debt Instrument [Line Items]  
Basis spread on variable rate (as a percent) 0.50%
Less Than 50% of Aggregate Commitment | SOFR Spread  
Debt Instrument [Line Items]  
Basis spread on variable rate (as a percent) 1.50%
v3.24.1.u1
Accounts Receivable Factoring - Narrative (Details)
€ in Millions, $ in Millions
3 Months Ended
Mar. 31, 2024
EUR (€)
Mar. 31, 2024
USD ($)
Mar. 31, 2023
USD ($)
Transfers and Servicing [Abstract]      
Proceeds from factoring of accounts receivable | $   $ 36.0 $ 36.0
Non U S maximum availability under these programs | € € 0    
v3.24.1.u1
Income Taxes - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Income Tax Disclosure [Abstract]      
Provision for income taxes $ 1.9 $ 4.2  
Unrecognized tax benefits $ 9.2   $ 9.1
v3.24.1.u1
Net Income Per Common Share - Reconciliation of the weighted average common shares outstanding used to compute basic and diluted net income (loss) per common share (Details) - shares
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Earnings Per Share [Abstract]    
Basic weighted average common shares outstanding (in shares) 35,265,449 35,121,473
Effect of dilutive securities - stock awards 795,191 626,548
Diluted weighted average common shares outstanding (in shares) 36,060,640 35,748,021
v3.24.1.u1
Net Income Per Share - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Earnings Per Share [Abstract]    
Number of anti-dilutive shares excluded from the calculation of diluted earnings per share 497,801 682,930
Dividends $ 0 $ 0
v3.24.1.u1
Equity - Narrative (Details) - USD ($)
$ / shares in Units, $ in Millions
Mar. 31, 2024
Dec. 31, 2023
Class Of Stock [Line Items]    
Common stock, shares authorized (in shares) 75,000,000 75,000,000
Par value of common stock (in dollars per share) $ 0.01  
Preferred stock, shares authorized (in shares) 3,500,000 3,500,000
Par value of preferred stock per share (in dollars per share) $ 0.01 $ 0.01
Preferred stock, shares issued (in shares) 0  
Common Stock    
Class Of Stock [Line Items]    
Stock repurchase program, remaining authorized amount $ 35.0  
Maximum | Common Stock    
Class Of Stock [Line Items]    
Stock repurchase program, authorized amount $ 35.0  
v3.24.1.u1
Equity - Reconciliation of Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Increase (Decrease) in Equity [Roll Forward]    
Beginning balance $ 603.3  
Total other comprehensive loss, net of income tax (12.5) $ (0.1)
Ending balance 596.0  
Gains and Losses on Cash Flow Hedges    
Increase (Decrease) in Equity [Roll Forward]    
Beginning balance 1.3 5.4
Other comprehensive Income (loss) before reclassifications (2.5) 0.1
Amounts reclassified from accumulated other comprehensive income (loss) 0.9 (3.4)
Total other comprehensive loss, net of income tax (1.6) (3.3)
Ending balance (0.3) 2.1
Pension & Postretirement    
Increase (Decrease) in Equity [Roll Forward]    
Beginning balance (10.3) (15.3)
Other comprehensive Income (loss) before reclassifications 0.0 (1.7)
Amounts reclassified from accumulated other comprehensive income (loss) 0.1 0.7
Total other comprehensive loss, net of income tax 0.1 (1.0)
Ending balance (10.2) (16.3)
Foreign Currency Translation    
Increase (Decrease) in Equity [Roll Forward]    
Beginning balance (77.4) (98.0)
Other comprehensive Income (loss) before reclassifications (11.0) 4.2
Amounts reclassified from accumulated other comprehensive income (loss) 0.0 0.0
Total other comprehensive loss, net of income tax (11.0) 4.2
Ending balance (88.4) (93.8)
Accumulated Other Comprehensive Loss    
Increase (Decrease) in Equity [Roll Forward]    
Beginning balance (86.4) (107.9)
Other comprehensive Income (loss) before reclassifications (13.5) 2.6
Amounts reclassified from accumulated other comprehensive income (loss) 1.0 (2.7)
Total other comprehensive loss, net of income tax (12.5) (0.1)
Ending balance $ (98.9) $ (108.0)
v3.24.1.u1
Equity - Reconciliation of Reclassifications From Accumulated Other Comprehensive Income (Loss), Net of Income Tax (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Schedule of Reclassifications out of Accumulated Comprehensive Income (Loss) [Line Items]    
Cost of sales $ 402.6 $ 402.0
Total before income taxes 6.4 20.7
Provision for income taxes 1.9 4.2
Net income 4.5 16.5
Other income (expense) - net 0.7 (1.1)
Reclassification out of Accumulated Other Comprehensive Income    
Schedule of Reclassifications out of Accumulated Comprehensive Income (Loss) [Line Items]    
Net income (1.0) 2.7
Gains and Losses on Cash Flow Hedges | Reclassification out of Accumulated Other Comprehensive Income    
Schedule of Reclassifications out of Accumulated Comprehensive Income (Loss) [Line Items]    
Total before income taxes (0.9) 3.4
Provision for income taxes 0.0 0.0
Net income (0.9) 3.4
Gains and Losses on Cash Flow Hedges | Reclassification out of Accumulated Other Comprehensive Income | Foreign Currency Exchange Contracts    
Schedule of Reclassifications out of Accumulated Comprehensive Income (Loss) [Line Items]    
Cost of sales (0.9) 3.4
Actuarial Losses | Reclassification out of Accumulated Other Comprehensive Income    
Schedule of Reclassifications out of Accumulated Comprehensive Income (Loss) [Line Items]    
Other income (expense) - net (0.1) (1.0)
Amortization of Prior Service Cost | Reclassification out of Accumulated Other Comprehensive Income    
Schedule of Reclassifications out of Accumulated Comprehensive Income (Loss) [Line Items]    
Other income (expense) - net 0.0 0.3
Pension & Postretirement | Reclassification out of Accumulated Other Comprehensive Income    
Schedule of Reclassifications out of Accumulated Comprehensive Income (Loss) [Line Items]    
Total before income taxes (0.1) (0.7)
Provision for income taxes 0.0 0.0
Net income $ (0.1) $ (0.7)
v3.24.1.u1
Stock-Based Compensation - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Stock-Based Compensation    
Share-based compensation, remaining shares available for issuance (in shares) 2,338,858  
Engineering, Selling and Administrative Expense    
Stock-Based Compensation    
Stock-based compensation expense (in dollars) $ 3.7 $ 3.1
Restricted Stock Units    
Stock-Based Compensation    
Granted (in shares) 443,019 478,411
Restricted Stock Units | Director    
Stock-Based Compensation    
Granted (in shares) 78,894 77,576
Performance Shares    
Stock-Based Compensation    
Granted (in shares) 365,174 233,409
2013 Omnibus Plan    
Stock-Based Compensation    
Share-based compensation, shares authorized (in shares) 7,477,395  
Performance Shares 2024 | Performance Shares    
Stock-Based Compensation    
Percentage of shares paid based on total shareholder return relative to peer group (as a percent) 60.00%  
Percentage of shares paid based on adjusted EBITDA (as a percent) 40.00%  
Increase decrease in percentage of shares paid based on total shareholder return relative to defined peer group 20.00%  
Performance period (in years) 3 years  
Percentage of shares of other than options granted during the period 200.00%  
Performance Shares 2023 | Performance Shares    
Stock-Based Compensation    
Percentage of shares paid based on total shareholder return relative to peer group (as a percent)   60.00%
Percentage of shares paid based on adjusted EBITDA (as a percent)   40.00%
Increase decrease in percentage of shares paid based on total shareholder return relative to defined peer group   20.00%
Performance period (in years)   3 years
Percentage of shares of other than options granted during the period   200.00%
v3.24.1.u1
Segments - Narrative (Details)
3 Months Ended
Mar. 31, 2024
Segment
Segment Reporting [Abstract]  
Number of reportable segments 3
v3.24.1.u1
Segments - Schedule of Information by Reportable Segment (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Segment Reporting Information [Line Items]    
Net sales $ 495.1 $ 508.3
Operating (loss) income 15.2 30.2
Depreciation 14.7 13.9
Capital Expenditures 12.2 10.6
Operating Segments    
Segment Reporting Information [Line Items]    
Operating (loss) income 25.9 40.7
Operating Segments | Americas    
Segment Reporting Information [Line Items]    
Net sales 283.2 264.4
Operating (loss) income 29.5 28.5
Depreciation 7.3 7.2
Capital Expenditures 4.2 4.4
Operating Segments | EURAF    
Segment Reporting Information [Line Items]    
Net sales 143.0 178.2
Operating (loss) income (11.8) 3.6
Depreciation 5.9 5.4
Capital Expenditures 7.2 4.7
Operating Segments | Middle East and Asia Pacific ("MEAP")    
Segment Reporting Information [Line Items]    
Net sales 68.9 65.7
Operating (loss) income 8.2 8.6
Depreciation 0.8 0.6
Capital Expenditures 0.8 1.5
Corporate    
Segment Reporting Information [Line Items]    
Operating (loss) income (10.7) (10.4)
Depreciation 0.7 0.7
Capital Expenditures $ 0.0 $ 0.0
v3.24.1.u1
Segments - Schedule of Reconciliation of the Company's Segment Operating Income (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Segment Reporting Reconciling Item For Operating Profit Loss From Segment To Consolidated [Line Items]    
Total operating income $ 15.2 $ 30.2
Unallocated restructuring expense 0.6 0.0
Operating Segments    
Segment Reporting Reconciling Item For Operating Profit Loss From Segment To Consolidated [Line Items]    
Total operating income 25.9 40.7
Corporate    
Segment Reporting Reconciling Item For Operating Profit Loss From Segment To Consolidated [Line Items]    
Total operating income (10.7) (10.4)
Material Reconciling Items    
Segment Reporting Reconciling Item For Operating Profit Loss From Segment To Consolidated [Line Items]    
Unallocated restructuring expense $ 0.0 $ (0.1)
v3.24.1.u1
Segments - Schedule of Net Sales by Geographic Area (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues from External Customers [Line Items]    
Net sales $ 495.1 $ 508.3
United States    
Revenues from External Customers [Line Items]    
Net sales 249.2 213.8
Europe    
Revenues from External Customers [Line Items]    
Net sales 138.2 174.4
Other    
Revenues from External Customers [Line Items]    
Net sales $ 107.7 $ 120.1
v3.24.1.u1
Segments - Schedule of Net Sales By Product (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Product Information [Line Items]    
Total net sales $ 495.1 $ 508.3
New Machine Sales [Member]    
Product Information [Line Items]    
Total net sales 349.9 357.3
Non-new Machine Sales [Member]    
Product Information [Line Items]    
Total net sales $ 145.2 $ 151.0
v3.24.1.u1
Commitments and Contingencies - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Commitments And Contingencies [Line Items]      
Period over which product liability self-insurance retention levels have varied (in years) 10 years    
Product liability reserves - Current $ 4.1   $ 11.4
Product liability reserves - Non-Current 5.8   5.1
Estimated insurance recoveries 0.5   3.9
Warranty claims reserves 52.6   56.8
Engineering, selling and administrative expenses 76.0 $ 75.1  
Statutory maximum penalties 174.0    
Accounts Payable and Accrued Expenses      
Commitments And Contingencies [Line Items]      
Commitment liability 36.1   $ 36.1
Maximum      
Commitments And Contingencies [Line Items]      
Product liability self-insurance maximum retention level for new occurrence $ 3.0    
v3.24.1.u1
Guarantees - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Product Warranty Liability [Line Items]    
Revenue deferred related to buyback obligations included in other current and non-current liabilities $ 30.4 $ 32.2
Amount of residual value buyback commitments and given by the company 40.9 43.4
Amount of loss guarantees with maximum liabilities 13.5 13.0
Revenue deferred related to extended warranties included in other current and non-current liabilities $ 7.3 $ 6.1
Standard product warranties, low end of range (in months) 12 months  
Standard product warranties, high end of range (in months) 60 months  
v3.24.1.u1
Guarantees - Summary of Warranty Activity (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Warranty activity    
Balance at beginning of period $ 56.8 $ 58.0
Adjustments to accruals for warranties 5.3 6.6
Settlements made (in cash or in kind) during the period (8.8) (8.5)
Currency translation (0.7) 0.3
Balance at end of period $ 52.6 $ 56.4
v3.24.1.u1
Restructuring - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Restructuring and Related Activities [Abstract]    
Restructuring expense $ 0.6 $ 0.0
v3.24.1.u1
Restructuring - Rollforward of all restructuring accrual (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Rollforward of all restructuring accrual    
Restructuring expense $ 0.6 $ 0.0
v3.24.1.u1
Employee Benefit Plans - Schedule of Components of Net Periodic Benefit Costs (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Pension Plans | United States    
Defined Benefit Plan Disclosure [Line Items]    
Service cost - benefits earned during the period $ 0.0 $ 0.0
Interest cost of projected benefit obligations 1.3 1.4
Expected return on plan assets (1.0) (1.0)
Amortization of prior service cost 0.0 0.0
Amortization of actuarial net (gain) loss 0.5 0.6
Net periodic benefit cost 0.8 1.0
Pension Plans | Non-U.S. Pension Plans    
Defined Benefit Plan Disclosure [Line Items]    
Service cost - benefits earned during the period 0.3 0.3
Interest cost of projected benefit obligations 0.7 0.7
Expected return on plan assets (0.4) (0.4)
Amortization of prior service cost 0.0 0.0
Amortization of actuarial net (gain) loss 0.0 0.4
Net periodic benefit cost 0.6 1.0
Postretirement Health and Other Plans    
Defined Benefit Plan Disclosure [Line Items]    
Service cost - benefits earned during the period 0.0 0.0
Interest cost of projected benefit obligations 0.1 0.1
Expected return on plan assets 0.0 0.0
Amortization of prior service cost 0.0 (0.3)
Amortization of actuarial net (gain) loss (0.4) 0.0
Net periodic benefit cost $ (0.3) $ (0.2)

Manitowoc (NYSE:MTW)
Gráfica de Acción Histórica
De Abr 2024 a May 2024 Haga Click aquí para más Gráficas Manitowoc.
Manitowoc (NYSE:MTW)
Gráfica de Acción Histórica
De May 2023 a May 2024 Haga Click aquí para más Gráficas Manitowoc.